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ABSTRACT
In Pax8-/- mice the thyroid anlage disappears around E11.5. At birth the gland
appears as a rudimentary structure composed only of C cells while thyroid
follicular cells are undetectable. Thus, this model does not allow the study of
Pax8 function in the postnatal thyroid.
To address the role of Pax8 in the differentiated thyroid, I  established novel
strains amenable to thyroid follicular cell-specific conditional knockout of
Pax8 gene using the Cre/lox system. A genetically modified mouse strain
(Pax8fl/fl) harbouring a floxed allele of Pax8 was generated. These mice were
crossed  with  two different Cre mice,  a Pax8Cre/+ strain expressing
constitutively  Cre recombinase by embryonic day 8.5 and a Tg-CreER strain in
which Cre is active in thyroid follicular cells following tamoxifen injection.
Pax8Cre/fl mice do not display an overt phenotype during embryonic life.
However, 3-week old Pax8Cre/fl pups show a hypothyroid phenotype
characterized by both an increased serum TSH value and a significant
reduction in body weight when compared with their wild type littermates. In
Pax8Cre/fl animals the thyroid gland  is hypoplastic and shows the absence of
the follicular structure; moreover, the expression of many thyroid specific
genes, required for both hormone production and regulative functions, is
completely abolished. In addition, survival of follicular cells is impaired.
The disruption of Pax8 in adult life (Pax8ko/fl;Tg-CreER strain) seems to be not
efficient and thyroid structure appears comparable to that of wild type.
However, the absence of a clear phenotype in the Pax8ko/fl;TgCreER thyroid
could be due to the compensatory  proliferation of cells in which Pax8 has not
been inactivated.
In conclusion, in my thesis work I demonstrated in vivo that Pax8 plays a key
role in controlling both the expression of many thyroid specific genes and the
survival of thyroid follicular cells.
Background
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1. BACKGROUND
1.1 The development of the  thyroid in mice
1.1.1 The organogenesis of the thyroid
The thyroid gland, a component of the endocrine system, is responsible for
producing thyroid hormone, known for its role in regulating metabolism in
adults and is also required for many developmental processes.
The mammalian thyroid gland consists of two elongated lobes, connected by a
very thin isthmus, located in front of the trachea, between the thyroid cartilage
and the fourth tracheal ring. The thyroid parenchyma is composed of various
epithelial cells. Thyroid follicular cells (TFCs), destined to produce thyroid
hormones, are most abundant and are organized in particular spheroid
structures known as follicles, each composed of a layer surrounding a closed
cavity containing the colloid. TFCs are highly differentiated and express a
number of proteins required for the synthesis and the release, in the blood, of
thyroid hormones.
Both the final structure of thyroid and the differentiation of TFCs occur during
embryonic life through a process, that in mice, starts around embryonic day (E)
8-8.5 and is completed by E16.5-17.
Thyroid anlage, the presumptive thyroid-forming district, is evident by E 8-8.5,
as a midline thickening of the endodermal epithelium in the ventral wall of the
primitive pharynx and is localized caudal to the so called tuberculum impar
(Kaufman and Bard 1999), the region of the first branchial arch that gives rise
to the median portion of the tongue. The thyroid anlage very shortly changes its
appearance: the thickened bud first appears as a depression in the endodermal
layer, evaginates from the floor of the pharynx and by E9 invades the
surrounding mesenchyme. By E9.5-10 thyroid anlage appears as a flask-like
structure that becomes a diverticulum and begins a caudal translocation
towards its final position (Di Lauro and De Felice 2003) (Fig. 1). The
migrating thyroid bud is connected to the pharynx by a narrow channel, the
thyroglossal duct, a transient structure that regresses and is no longer visible by
E11.5. On E12-12.5, the thyroid bud shows proliferation and grows laterally
continuing its downward migration. At E13-14, the developing thyroid reaches
its definitive pre-tracheal position and joins with the ultimobranchial bodies,
which are the transient embryonic structures derived from the fourth
pharyngeal pouch and contain the precursors of calcitonin-producing cells.
The two rudimentary para-tracheal lobes expand by E15-16 and the thyroid
gland assumes its definitive shape. TFCs start organizing into cords of cells
forming small rudimentary follicles. In the late fetal life, thyroid increases in
size and its parenchyma is organized into small follicles, surrounded by a
capillary network, enclosing thyroglobulin in their lumen At birth, thyroid
gland is able to produce and release thyroid hormones though the regulation of
Background
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its growth and function by the hypothalamic-pituitary axis is fully active only
after birth (De Felice et al. 2004).
(c)
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Thyroglossal duct
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Hyoid bone
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(b)
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Hyoid bone
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Oesophagus
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Figure 1 Development of thyroid in mouse. (a) Formation of the thyroid bud and diverticulum. (b) The
developing thyroid extends caudally forming the thyroglossal duct which (c) disappears as the thyroid
reaches its destination. (d) The thyroid gland in situ. The developmetal stage is indicated in embryonic
(E) day.
(From Di Lauro and De Felice 2003)
1.1.2 The differentiation of thyroid follicular cells
As soon as the thyroid anlage is visible as an endodermal thickening in the
midline of the floor of the primitive pharynx, the precursors of TFCs acquire a
specific molecular signature and can be distinguished by the co-expression of
four transcription factors Hhex (Thomas et al. 1998), Titf1 (Lazzaro et al.
Background
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1991), Pax8 (Lazzaro et al. 1991) and Foxe1 (Zannini et al. 1997). It is worth
noting that each of these transcription factors is expressed also in other tissues
but such a combination is a unique hallmark of both differentiated thyroid
follicular cells and their precursors (Damante et al. 2001). Studies in animal
models have shown the relevance of these factors for thyroid development. In
the absence of either Titf1, Hhex, Pax8 or Foxe1 the thyroid anlage is correctly
formed but the subsequent thyroid morphogenesis is severely impaired (Parlato
et al. 2004). The presence of Titf1 (Kimura et al. 1996; Kimura et al. 1999),
Hhex (Martinez Barbera et al. 2000) and Pax8 (Mansouri et al. 1998) is
required for the survival of the TFC precursors, whereas in the absence of
Foxe1 the thyroid primordium either disappears or remains in a sub-lingual
ectopic position (De Felice et al. 1998). These data indicate that Titf1, Hhex,
Pax8 and Foxe1 play individual roles in the organogenesis of the gland;
however functional interaction among these factors has been demonstrated in
developing thyroid (Fig. 2).
Figure 2 Functional interactions among Hhex, Titf1, Pax8 and Foxe1 in developing thyroid. The
transcription factor and the functions controlled by it are indicated in different colours. Each factor
regulates other transcription factors controlling the onset (arrow) or the maintenance (square) of their
expression.
(From Parlato et al. 2004)
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SPECIFICATION
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Actually, Titf1, Hhex and Pax8 are linked in a complex regulatory network
because each of them controls the maintenance of expression of the other
factors. The simultaneous presence of these three factors is required for the
expression of Foxe1, suggesting that Foxe1 is located downstream in the
thyroid regulatory network (Parlato et al. 2004).
Shortly after specification, TFC precursors begin to translocate to reach the
sub-laryngeal position, a process that lasts for almost four days. The expression
of transcription factors such as either Hhex or Pax8 or Titf1 is not sufficient for
thyroid migration, while Foxe1 plays a crucial role because the presence of this
factor in the thyroid bud is required to allow the cells to move (De Felice et al.
1998; Parlato et al. 2004). Thus, in TFC precursors, Foxe1 is likely to control
the expression of key molecules required for migration, though it has been
suggested that the translocation of thyroid primordium towards the sub-
laryngeal position not only depends on cell autonomous events but could also
be driven by the movements of other surrounding tissues of the neck region
(Hilfer and Brown 1984).
When the thyroid primordium reaches the sub-laryngeal position, TFC
precursors accomplish their functional differentiation and the gland acquires its
definitive shape, two lobes connected by an isthmus. The process leading to the
formation of the two lateral lobes of the gland seems to be controlled by
inductive signals originating from adjacent structures, mainly the vessels
located close to the thyroid tissue. This is observed in mice in which, when
either Sonic hedgehog (Shh) (Fagman et al. 2004) or TBX1 (Fagman et al.
2006) has been disrupted, correct patterning of the vessels is disturbed; the
lobulation process is impaired and the thyroid gland assumes the shape of a
single midline mass located lateral to the trachea.
The final differentiation of TFC is featured by the expression of a number of
genes required for thyroid function such as thyroglobulin (Tg), thyroid
peroxidase (TPO), TSH receptor (Tshr); sodium/iodide symporter (NIS),
thyroid oxidases (Thox’s) and pendrin (PDS). The final differentiation program
of TFC requires almost three days. Tg appears around E14 (Lazzaro et al.
1991) while thyroxine is first detected at E16.5 (Meunier et al. 2003). The
expression of both TPO and NIS, the two key enzymes involved in the process
of Tg iodination, is absolutely dependent on the pathway activated by the
binding of TSH to its receptor, Tshr (Postiglione et al. 2002). It is worth noting
that in mice, this pathway is not much relevant for the expansion of the fetal
thyroid; in contrast, the growth of adult thyroid is dependent on
TSH/Tshr/cAMP signals (De Felice et al. 2004). Thus, some characteristics are
acquired by TFCs only after birth.
Background
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1.2 Genetically modified mice  for the study of thyroid gland development
In recent years, genes and mechanisms involved in thyroid morphogenesis
have been partially  identified. These finding are due to studies on murine
models generated in gene targeting experiments.
Gene targeting in mice allows defined modifications, such as deletions,
insertions, and point mutations, to be made at specific points in the mouse
genome. This is achieved in cells by homologous recombination of a targeting
vector that contains the desired change (Thomas and Capecchi 1987). This is
normally carried out in embryonic stem (ES) cells as these cells have high rates
of homologous recombination and are able to contribute to the germline when
re-introduced into mouse embryos at the morula or blastocyst stage of
development (van der Weyden et al. 2002; Bradley  A 1991; Bradley A 1993).
The generation of murine strains  in which  thyroid relevant genes have been
disrupted has provided useful animal models to study the genetic mechanisms
of thyroid development. In addition, these models have been valuable in
elucidating the molecular pathology of thyroid dysgenesis, the most frequent
cause of congenital hypothyroidism.
Hhex knock-out mice
During development Hhex is also expressed in the primordium of several
organs derived from the foregut, including thyroid bud. Hhex is an early
marker of thyroid cells, since it is present in the thyroid anlage at E 8-8.5
(Thomas et al. 1998) at the same stage in which Titf1, Foxe1 and Pax8 are
detected. The analysis of Hhex-/- embryos has revealed that this factor is
absolutely necessary for thyroid morphogenesis (Martinez-Barbera et al. 2000).
In Hhex null embryos, at E8.5, TFCs are present in the anterior wall of the
pharynx (Parlato et al. 2000). One day later the thyroid primordium is absent or
hypoplastic and the thyroid precursor cells do not express Titf1, Foxe1 and
Pax8 (Martinez-Barbera et al. 2000) . Hence at early stages of development,
the presence of Hhex could be required to maintain the expression of Titf1,
Foxe1 and Pax8 in the thyroid primordium.
Titf1 knock-out mice
Titf1 (or Nkx2-1) was initially identified in a rat thyroid cell line (Civitareale et
al. 1989) as a nuclear protein able to bind to specific sequences in the Tg
promoter.
Titf1 is expressed in both differentiated follicular cells and in their precursors.
It is detected in the thyroid primordium as soon as the thyroid anlage is visible.
In the thyroid gland, Titf1 expression is not restricted to the follicular cells; it is
also present in parafollicular C-cells (Suzuki et al. 1998). In addition, Titf1 is
Background
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expressed in selected areas of the forebrain, including the developing posterior
pituitary, in the trachea and in the lung epithelium (Lazzaro et al. 1991).
Gene targeting experiments have allowed the study of the role of this
transcription factor during embryonic life. Mice, in which both Titf1 alleles
have been disrupted, show a complex phenotype according to the wide
expression domain of this gene.
In absence of Titf1, the newborn mice immediately die at birth and are
characterized by impaired lung morphogenesis, lack of thyroid (Fig.3) and
pituitary and severe alterations in the ventral region of the forebrain (Kimura et
al. 1996)
Figure 3 Sagittal sections of wild-type (A) and Titf1-/- (B) E15.5 embryos stained with Pax8
antibody. In wild-type embryo, the developing thyroid (arrow) is positioned dorsal to the cricoid
cartilage. In the mutated embryo the thyroid tissue is undetectable (arrowhead). Cr: Cricoid cartilage; ph:
pharynx (De Felice and Di Lauro 2004).
Analyses during development demonstrate that the thyroid anlage forms in its
correct position but at an early stage, morphogenesis of the gland is impaired.
The thyroid primordium by E10.5 appears much smaller in size in comparison
to wild type and subsequently undergoes degeneration probably in
consequence of an apoptotic process (Kimura et al. 1996). Hence, Titf1 is
dispensable for the initial commitment of thyroid cells, but is required for the
survival and subsequent differentiation of the cells. However, we do not know
which genes are controlled by this transcription factor in the thyroid
primordium.
Pax8 knock-out mice
Pax8 is expressed in adult and developing thyroid since the early stages of
gland morphogenesis. In addition, Pax8 is initially but transiently expressed in
the myelencephalon and through the entire length of the neural tube during
embryonic life (Plachov et al. 1990) and is present in the developing kidneys,
where it is maintained throughout adult life.
Analysis of Pax8-/- mice (Mansouri et al. 1998) offers the possibility of
studying the role of this transcription factor in embryonic life. Pax8 null pups
show growth retardation and die within 2-3 weeks of their birth. The animals
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are affected by a severe hypothyroidism and present a rudimental gland
composed almost completely of calcitonin-producing C cells while the TFCs
are absent (Fig. 4). In Pax8 null embryos the thyroid anlage forms, evaginates
from the endoderm and begins to migrate into the mesenchyme. However by
E11 the thyroid bud is smaller in comparison to that of wild type. In addition,
other transcription factors, such as Foxe1 and Hhex, are down-regulated in the
precursors of thyroid cells in the absence of Pax8 (Parlato et al. 2000). Finally,
by E12.5 TFC is not detectable (Mansouri et al. 1998).
Thus, during morphogenesis, Pax8 holds a specific upper role in the genetic
regulatory cascade that controls thyroid development and it is required for the
survival of the TFCs and to maintain the tissue-specific gene expression
program.
Figure 4 Analysis of calcitonin-producing cells in the thyroid gland of Pax8-/- mouse embryos.
Sagittal sections control embryos (a,b) and Pax8-/- embryos (c,d) stained with haematoxylin/eosin (a,c)
and immunohistochemistry using anti-calcitonin antibody (b,d). (Mansouri et al. 1998)
Foxe1 knock-out mice
Foxe1 was originally identified as a thyroid specific nuclear protein that can
bind to a sequence present on both Tg and TPO promoters under insulin, IGF-1
or TSH stimulation (Santisteban et al. 1992).
Foxe1 is detected in the thyroid primordium and its expression is maintained in
TFCs during all stages of development and in adulthood. during embryonic
life, has a wide domain of expression. Indeed, at early stages of development,
Foxe1 is detected in the endodermal epithelium lining the primitive pharynx,
the arches and the foregut and transiently in the Rathke's pouch. Subsequently
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Foxe1 is expressed also in the tongue, in the secondary palate, in the definitive
choanae, and in the whiskers and hair follicles (Dathan et al. 2002). Analysis of
Foxe1 null mice revealed the role of this transcription factor in thyroid
development. Targeting inactivation of Foxe1 shows that homozygous Foxe1-/-
mice are born at the expected Mendelian ratio but die within 48 hours. These
mice display a severe cleft palate, probably responsible for the prenatal death,
no thyroid in its normal location, absence of thyroid hormones and elevated
TSH levels in the bloodstream (De Felice et al. 1998). In Foxe1-/- embryos, at
early stages of thyroid morphogenesis, the formation of the thyroid anlage is
not affected. However, at E10 in Foxe1 null embryos, TFCs are still on the
floor of the pharynx whereas in wild type embryos the thyroid primordium
begins to descend towards its final location.
Figure 5 Analysis of Foxe1-/- newborn phenotype. Sagittal sections through the thyroid region of
Foxe1+/– (a) or Foxe1–/– (b) mice. Thyroid is adjacent to cricoid cartilage in normal mouse and absent (*)
in homozygous mouse. (De Felice et al. 1998)
ps, palatal shelves; Cr, cricoid cartilage; Tm, thymus.
At later stages of development, in the absence of Foxe1, TFCs either disappear
(Fig.5) or form a small thyroid remnant still attached to the pharyngeal floor. In
this case, the cells are able to go on their differentiative program as tested by
the synthesis of thyroglobulin. These data indicate that in embryonic life Foxe1
has a specific role in controlling the migration of TFC precursors, but is not
relevant for the specification and differentiation of the thyroid anlage. In
addition, Foxe1 could be involved in the survival of TFCs since in many Foxe1
null embryos the thyroid primordium disappears (De Felice et al. 1998; Parlato
et al. 2004).
Tshr knock-out mice
Tshr (thyroid stimulating hormone receptor) is detected in TFC precursors by
E14-14.5 (Lazzaro D et al. 1991; Brown RS et al. 2000). At later stages of
development Tshr expression increases and remains expressed in adult life.
The role  of TSH/Tshr signaling in vivo during embryonic life has been studied
in genetically modified mice in which Tshr gene has been disrupted by
A B
C Da b
Background
17
homologous recombination (Tshr-/-) mice (Marians RC et al. 2002). E16 mouse
embryos deprived of TSH/Tshr signaling do not show defects in morphology
of the gland which displays a normal size and follicular structure though both
TPO and NIS are undetectable in TFCs (Postiglione MP et al. 2002). During
thyroid morphogenesis TSH pathway is absolutely required for the
differentiation process of the thyroid but it does not appear to be relevant for
the growth of the gland. On the contrary, adult Tshr-/- mice display a severe
hypoplastic adult thyroid (Marians RC et al. 2002; Postiglione MP et al. 2002).
1.3. Pax8 in differentiated thyroid follicular cells
Pax8 is a paired domain containing transcription factor and belongs to the Pax
family of transcription factors. In mice Pax8 gene is split in 12 exons
(Okladnova O et al. 1997); alternative splicing produces transcripts that differ
in their carboxy-terminal regions. It has been demonstrated that the expression
of different isoforms is temporally and spatially regulated during early mouse
development. Furthermore PAX8 isoforms display different trans-activating
activities when tested in cell lines.
In Pax8 null mice mature TFCs are absent making it difficult  to reveal the role
of this factor in the control of adult thyroid function. All the available data on
Pax8 functions in differentiated cells, come from studies on cell lines in
culture. Consensus sequences recognized by Pax8 have been found in the
proximal promoters of Tg and TPO and in an upstream enhancer of NIS (Ohno
M et al. 1999). In both Tg and TPO proximal promoters,  Pax8 binding sites
partially overlap Titf1 binding sequences (Zannini MS et al. 1992); in NIS
enhancer the two Pax8 sites flank a cAMP response element and recently it has
been shown that Pax8 is able to bind in vitro to the 5-flanking region of Foxe1
and ThOX2 genes (D'Andrea B et al. 2006).
Functional assays carried out in non thyroid cell lines have demonstrated that
Pax8 is required to activate the TPO promoter and to a less extent  the Tg
promoter (Zannini MS et al. 1992) and NIS enhancer (Ohno M et al. 1999). In
addition, it has been demonstrated that in transformed thyroid cells Pax8 is
sufficient to activate expression of the endogenous genes encoding Tg, TPO
and NIS. These data suggest that Pax8 has an important role in the maintenance
of functional differentiation in thyroid cells (Pasca di Magliano M et al. 2000).
It is worth noting that Pax8 is  expressed together Tif1 only in TFCs. Both of
them bind to sequences present in the regulative regions of thyroid specific
genes; furthermore the Pax8 binding site overlaps with the Titf1 binding site on
both Tg and TPO promoters (Zannini MS et al. 1992). These findings suggest
some interaction between Titf1 and Pax8. In fact co-immunoprecipitation
experiments in thyroid cells have shown that Titf1 and Pax8 form in vivo, a
protein complex, which is probably  mediated by protein-protein interaction
since it does not require the binding to DNA (Di Palma et al. 2003). Titf1 and
Pax8 have also functional interactions, since the two factors cooperate in a
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synergistic manner in activating Tg promoter. This functional interaction is
mediated by the N-terminal domain of Titf1 and the C-terminal part of Pax8. It
is worth noting that the synergistic effect of Titf1 and Pax8 is manifested on
the minimal region of Tg promoter while it is not effective on TPO minimal
promoter (Di Palma et al. 2003). In addition to the synergistic cooperation
between Pax8 and Titf1, Pax8 can interact with other proteins which can be
responsible for the target preferences in definite cell types or developmental
stages. Assays in vitro have indicated a potential interaction between Pax8 and
WBP-2, a protein containing a WW domain, a 40 amino acid long sequence
involved in protein interactions (Nitsch R et al. 2004).  WBP-2 is an ubiquitous
protein but an alternatively spliced isoform of this protein seems to be
expressed only in thyroid. Though the interaction between Pax8 and WBP-2 is
found to be effective also in vivo there is no proof that the transcriptional
activity of Pax8 is modulated in consequence to this interaction.
1.4. Conditional knock-out  for the study of  adult thyroid
Germline disruption of many genes results in early prenatal or even early
embryonic death. In other cases the development of the organ of interest is
blocked at an early stage thus preventing the study of late events of the
morphogenesis. This is the case of the already generated thyroid mouse
models. In Titf1, Foxe1, Hhex and  Pax8 null mice the thyroid disappears at an
early stage (around  E11); it is impossible to study  the role of some of these
genes in the differentiated follicular cells and in the physiology of the gland.
Hence, it is important to generate models in which the gene of interest is
disrupted in both a specific  stage and a specific tissue.
These problems can be resolved by conditional gene deletions which make use
of the properties of recombinases to recognise specific target sequences that
can be introduced into genomic DNA. The most common system used in mice
is the Cre/loxP system (Hoess RH et al. 1982) (Fig. 6).
This makes use of the P1 bacteriophage Cre recombinase that recognises loxP
sites, a 34 bp sequence that comprises two 13-bp inverted repeats flanking an 8
bp spacer region (Fig. 6a). This 8 bp sequence confers directionality on the
loxP site; if two loxP sites are present in opposite orientations in a DNA
sequence, Cre will catalyse the inversion of the intervening sequence. If both
loxP sites are present in the same orientation then Cre will catalyse the removal
of the intervening sequence (Fig. 6 c,d).
For conditional deletions, the gene of interest is modified to introduce loxP
sites in the intron 5’ and 3’ to a selected group of exons that are essential to the
function of the gene. These loxP sites do not interfere with the transcription of
the gene, so the mice with this modified allele should be normal. If, however,
Cre is expressed in the cells of these mice, the exons between the loxP sites
will be deleted, resulting in a knock-out allele.
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Figure 6 Cre target site and mechanism of the Cre-mediated recombination. (a) Cre recombinase
target site, horizontal arrows mark the inverted repeats and the triangle the spacer; (b) Synaptic complex
formed between recombinase molecules and two identical target sites. One recombinase monomer binds
each 13 bp repeat, while the spacer sequence provides the site of strand cleavage, exchange (via a
Holliday intermediate) and ligation. In the final product, there is an exchange of DNA between the two
starting sites.
Cre expression can be achieved using viruses, although the most common
method is to cross the mice to a Cre-expressing strain. Many Cre-expressing
mouse models have been made, including ones which express Cre under the
control of inducible or tissue specific promoters, thereby allowing control of
where and when the deletion occurs.
1.4.1 Mouse strains already available used in this thesis
In my thesis work I used two different Cre-driver mice, a Pax8Cre/+ (Bouchard
et al, 2004)  and a  Tg-CreER strain, both already available in the laboratory.
The Pax8-Cre mouse is a knock-in model obtained by inserting a cre gene in-
frame into Pax8 exon 3 (Fig. 7a), in this way the expression pattern of the
recombinase reflects that of the Pax8 gene (Fig. 7b), in fact it starts to be
detected at E8,5 in the thyroid gland, inner ear, kidney and in the mid-
hindbrain boundary region.
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Figure 7 Generation of the Pax8-Cre mouse. (a) Structure of wild-type and mutant Pax8 alleles; (b) β-
Galactosidase assay on embryo at E9.5 obtained by crossing Pax8Cre/+ mice with Rosa26-LacZ mouse.
Rosa 26-LacZ is a knock in mouse expressing the reporter gene LacZ under the control of the ubiquitous
promoter Rosa26
The Tg-CreER strain is a transgenic mouse model in which a Cre, under the
control of the thyroglobulin promoter, has been fused to a mutated form of the
ligand binding domain of the estrogen receptor. The mutant ER does not bind
its natural ligand at physiological concentrations, but binds to a synthetic
ligand, tamoxifen. Thus, CreER activity can be induced following tamoxifen
injection, thereby allowing the temporal deletion of the loxP flanked gene (Fig.
8).
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Figure 8 β-Galactosidase assay performed on adult thyroids of Rosa26-LacZ::TgCreER mice. Only
when the mice are injected with tamoxifen the Cre recombinase is active and the reporter gene is
expressed.
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2. AIMS OF THE STUDY
Pax8 is absolutely  required for the development  of the thyroid. Thanks to an
animal model ( Pax8-/- mice) we know that this transcription factor controls the
survival of thyroid precursor cells. However, In Pax8 null mice mature thyroid
follicular cells  are absent, making it difficult  to reveal the role of this factor in
the adult thyroid.
Experiments in thyroid cell lines have shown that Pax8 has an essential role in
the maintenance of the phenotype of thyroid follicular cells, controlling the
expression of several thyroid specific genes, essential for the production of
thyroid hormones.  Pax8 activates the expression of the endogenous genes
encoding Tg, TPO and NIS at their chromosomal locus. Furthermore, in thyroid
transformed cell lines re-activation of Pax8 expression can restore a
differentiated thyroid phenotype.
Despite of the essential role played by Pax8 in thyroid follicular cells, we do
not have any animal models to study the role of this factor in vivo; all the
available data on Pax8 functions in differentiated cells come from studies on
cell lines in culture. Sometimes, studies in cell lines may not be an exhaustive
model  for the understanding of the complex role of a transcription factor in
vivo.
The aim of my thesis is to contribute to the study of Pax8 in the physiology of
the thyroid gland by generating and analyzing the phenotype of a novel
genetically modified mouse strain in which it is possible to disrupt the Pax8
gene in a controlled manner.
The availability of mouse strains expressing Cre recombinase in thyroid cells
has allowed me to use a strategy based on the Cre/lox system to accomplish my
goal.
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3. MATERIALS AND METHODS
3.1 Targeting vector and Generation of Pax8fl/+ mouse
To design of Pax8 conditional knock-out (cKO) allele we considered two main
objectives:
1) a pair of loxP sites must be inserted into intron regions of the target gene
such that the encoded protein is inactivated through Cre-mediated excision of
the loxP-flanked exons;
2) the target gene should not be disrupted by the presence of the loxP sites
prior to Cre-mediated recombination. Hence, we decided to flank the exons 3
and 4 of Pax8, since they codify for the DNA binding domain, essential for the
transcription factor functionality.
To generate the construct, we used the recombineering, or Red/ET
recombination, method, a technique that allows for the insertion, deletion, or
mutation of DNA sequences, assuaging the need for conveniently located
restriction sites. By this method, the target DNA molecules are precisely
altered by homologous recombination in strains of E. coli which express three
phage proteins, Gam, Beta and Exo, which are collectively called Red proteins
(Zhang et al 1998, Copeland et al 2001, Court et al 2002). The Gam protein
inhibits RecBCD and SbcCD exonuclease activities of E. coli, thus preserving
linear dsDNA and allowing it to be used as a substrate for recombination
(Sawitzke et al 2007); Beta protein is a single-stranded DNA (ssDNA)-binding
protein that promotes annealing of complementary DNA strands (Court et al
2002, Mythili 1996). Beta can bind stably to ssDNA longer than 35 nucleotides
and can protect ssDNA overhangs from single-strand nuclease degradation.
Exo is a dsDNA-dependent 5’-3’ exonuclease that processes linear dsDNA and
generates a 3’ ssDNA overhang at each end, the substrate that Beta protein
binds (Cassuto E 1971). A functional interaction between Exo and Beta is
required in order to catalyse the homologous recombination reaction.
In figure 9 the mechanism of Red/ET recombination is illustrated.
Recombination occurs through homology regions, which are stretches of DNA
shared by the two molecules that recombine.
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Figure 9 Mechanism of Red/ET recombination. (a) a double-stranded-break (DSB) repair is initiated
by Exo; (b,c) first Exo degrades the DNA in a 5’-3’ direction, starting from the DSB, thereby creating a
3’ ssDNA overhang; (d) Beta binds to the ssDNA forming a recombinogenic proteonucleic filament
which is used in recombination, either by single strand annealing or by strand invasion.
A double-stranded break repair is initiated by the recombinase protein, Exo,
that digests one strand of the DNA from the double-stranded break, leaving the
other strand as a 3’ ended, single-stranded DNA overhang. Then Beta binds
and coats the single strand and the protein-nucleic acid filament aligns with
homologous DNA. Once aligned, the 3’ end becomes a primer for DNA
replication.
Using this technique, it is possible to target and modify, by insertion or
deletion, any DNA sequence.
The process of generating the Pax8 conditional knock-out targeting vector was
consisted of three main steps:
1) retrieval of genomic region of interest from a bacterial artificial
chromosome (BAC) onto targeting vector  backbone by gap repair;
2) insertion of an orphan loxP site;
3) insertion of FRT-neo-FRT-loxP cassette with the same orientation of the
orphan loxP site.
Retrieval of genomic region of interest from a BAC onto targeting vector
backbone
The BAC chosen to generate the Pax8 cKO targeting vector, bMQ241m1 (The
Wellcome Trust Sanger Institute, Hinxton, UK), derive from a mouse 129Sv
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genomic DNAs library, that is isogenic with the genomic DNA of the ES cells
used for the homologous recombination, R1 (Nagy Basic ES cell line R1 129
strain); in this way the efficiency of homologous recombination is increased.
To retrieve the genomic region of interest from the BAC, a couple of primers
of 70 bp in length was designed to amplify by PCR the pBluescript II KS -
(Stratagene) backbone. These primers consist of two parts, 20 bp at the 3’ end,
that is useful for the amplification of pBS, and 50 bp at 5’, that represents the
homology arm designed to mediate the recombineering (Fig. 10).
BAC
(bMQ241m1) 32 4 5 6 7 8 9
ScaI ScaI
AmpR
pBlueScript
AmpR
pBlueScript
3 4 5 6 7 8 9
Figure 10 Retrieval of the gene sequence from the BAC by gap repair. The pBluescript backbone was
amplified by PCR and the resulting product was a linear plasmid with 50 bp in length homology arms
(thin red layer) at both ends, that are able to mediate the retrieving of the genomic sequence of interest
from the BAC  by gap repair. The positive bacterial clones were selected by ampicillin resistance. Black
boxes indicate the coding regions, the exons are numerated. AmpR, ampicilline-resistance cassette.
Insertion of an orphan loxP site
To insert the loxP orphan site, a second couple of primers, 70 bp in length, was
designed to amplify a loxP-neo-loxP cassette from the pL452 plasmid (from
National Cancer Institute – Frederick). Each primer was composed of 50 bases
homologous to the region that is going to be targeted, and 20 bases
homologous to the flanking regions of loxP-neo-loxP cassette; this allow the
insertion of loxP-neo-loxP cassette, with screening in bacteria using
kanamycin. To remove the neo cassette and leave an orphan loxP site, a Cre
recombinase-mediated reciprocal recombination of loxP sites was carried out
in bacterial strains (Fig. 11).
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Figure 11 Insertion of an orphan loxP site. (A) loxP-Neo-loxP cassette was amplified by PCR, adding
in the same time the 50 bp homology arms at both ends of this cassette (green and yellow thin layers).
Recombination between homologous regions allows to insert the loxP-neo-loxP cassette. The positive
clones were selected by kanamycin resistance; (B) bacteria containing the retrieved genomic region with
the loxP-Neo-loxP cassette  were electroporated with a Cre-expressing plasmid, Cre-mediated
recombination generates an orphan loxP. Black boxes indicate the coding regions, the exons are
numerated. AmpR, ampicilline-resistance cassette. Grey triangles indicate loxP sites, the red box
represent the neo-resistant cassette.
Insertion of FRT-neo-FRT-loxP cassette
For this step, the same principle used for the insertion of the loxP-neo-loxP was
followed (Fig. 12).
AmpR
pBlueScript
3 4 5 6 7 8 9
Neo
Neo
pL451
~7 kb
Figure 12 Insertion of a FRT-neo-FRT-loxP cassette. FRT-Neo-FRT-loxP cassette was amplified by
PCR, from the pL451 plasmid (from National Cancer Institute – Frederick) adding in the same time the
50 bp homology arms at both ends of this cassette (green and yellow thin layers). Recombination between
homologous regions allows to insert the FRT-neo-FRT-loxP cassette. The positive clones were selected
by kanamycin resistance. Black boxes indicate the coding regions, the exons are numerated. AmpR,
ampicilline-resistance cassette. Grey triangles and shadow boxes indicate loxP sites, respectively; the red
box represent the neo-resistant cassette.
Electroporation of the targeting vector in the ES cells
The R1 ES cells were maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 15% FBS (EuroClone), 1/100 L-glutamine
(Invitrogen), 1/100 NEAA (Invitrogen), 1/100 penicillin/streptomycin, 500
U/mL (Invitrogen), 1/500 2-mercaptoethanol, 1/10000 Lif (EuroClone) and
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1/100 Na pyruvate. They were electroporated with the linearized targeting
vector DNA using the MicroPorator MP-100 Digital Bio.
G418- resistant ES clones were selected, expanded and analyzed by PCR for
detection of homologous recombinant, as described in Results and Discussion.
The correctly targeted ES cells were electroporated with a FLP-expressing
plasmid, pCAGGS-FlpeIRESPURO, to delete the pGK-Neo cassette by
recombination between the FRT sites. Neomycin gene deletion  was confirmed
by PCR and the ES clones positive at this screening were injected into
C57BL/6 blastocysts to generate  chimeric founder mice as previously
described (Hogan et al. 1994, Joiner 1993). Chimeric founder male mice were
bred with C57BL/6 females. The germline-transmitted F1 mice were further
crossed with Pax8 heterozygous mice (ko/+ and Cre/+), and with Tg-CreER
transgenic mice to generate all the mice used for the several experiments.
3.2  Mouse lines
Heterozygous Pax8-Cre mice (Pax8Cre/+)were obtained  from the Meinard
Busslinger group (The Research Institute of Molecular Pathology, IMP,
Vienna, Austria), the heterozygous Pax8 null mice (Pax8ko/+) from Prof. P.
Gruss (Max Planck Institute, Goetting, Germany) and Tg-CreER transgenic
mice from Prof.G. Schutz (DKFZ, Heidelberg, Germany). Wild type C57BL/6J
(B6) and 129/SvPasCrl (Sv) mice were purchased from Charles River
Laboratories.
Animals were housed in an animal house under controlled conditions of
temperature (22±1°C), humidity (55±10%) and lighting on a 12-h light/12-h
dark cycle and were supplied with standard rodent food and water ad libitum.
3.3 ES cells screening
ES cells were screened both by polymerase chain reaction (PCR) and Southern
blotting.
Both analysis were performed on the genomic DNA isolated from Es cell
clones in 96-well plates by an over night incubation at 60°C with 50 µL of lysis
buffer (10 mM Tris pH 7.5, 10 mM EDTA pH 8, 10 mM NaCl, 0,5 % sarcosyl
with 1.0 mg/ml Proteinase K); the next day 150 µl of cold NaCl/ethanol (75
µM NaCl, in EtOH 100%) is added to each well and incubated for 2 days to
4°C. the DNA pellets are rinsed two-three times with EtOH 70% and
resuspended in appropriate volume of distilled water.
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PCR screening
I carried out the PCR analysis using the kit “Expand Long Template PCR
System” (Roche), according with the manufacturer’s procedure, using the
following primers:
F1: 5’-AATCACCTAGAGAAGTCCAC
R1: 5’-CCATGGGGAGGTTGAATGGC
NeoR: 5’-GGGATCGGCCATTGAACAAGATGG
Southern screening
The genomic DNA samples were cut with ScaI and the digestion fragments
were resolved on a 0.8% (w/v) agarose gel, followed by transfer to a Hybond
N+ membrane (Amersham Pharmacia Life Science). Hybridization and
detection were performed in accordance with the DIG system protocol
(Roche). I amplified the probe with the following couple of primers:
SouthF: 5’-TTAGATCTGCTCCATCACATTCGGG
SouthR: 5’- TGTACTAGGCACTCAGCAGGTATGGG
The PCR product was extracted from the gel by “QIAEX II Gel Extraction
Kit” (Quiagen), according with manufacturer’s protocol. To DIG-label the
probe, I used 10 pg of this product as template for a second PCR performed
with the same oligonucleotides with “PCR DIG Probe Synthesis Kit” (Roche).
3.4 Mice screening
All the mice and the embryos described in the present work were genotyped by
polymerase chain reaction (PCR) using genomic DNA isolated from the tail
clips or yolk sacs.
The tail clips or yolk sacs were incubated over night at 55°C in 700 µL or 500
µL of lysis buffer (50 mM Tris pH 7.5, 100 mM EDTA pH 8, 100 mM NaCl,
1% SDS with 1.0 mg/ml Proteinase K) respectively. The following day
genomic DNA was extracted adding 0.3 volumes of 6 M NaCl and precipitated
with isopropanol. After washing with 70% ethanol, the DNA pellet was
drained at room temperature (RT) and resuspended in appropriate volume of
distilled water.
PCR primers
To genotype heterozygous mice for the floxed allele, the PCR was set up so as
to identify both the wild type and the recombinant allele using a couple of
primers designed at the ends of the loxP inserted in the intron 2 of the gene:
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Int2F:  5’-GAAAGTTCGAGGGAAGGGAGATC
Pa1R:  5’-CAGTTCTTTCAGTGGTCCCTCC
These primers amplify a 395 bp product on the recombinant allele and a 300 bp
product on the wild type.
To genotype Pax8 heterozygous mice (ko/+), the PCR was set up so as to
identify both the wild type and recombinant locus in a single reaction using
three different primers: one common forward primer and two reverse primers,
one specific for Pax8 wild-type and the other one specific for Pax8 null allele.
The primers used for the amplification were as follows:
wdb: 5’-ATGCTAAGAGAAGGTGGATGAG (in the intron 3)
wrb: 5’-GTTGATGGAGCTGACACTG (in the exon 4)
krb: 5’-TGCACGAGACTAGTGAGAC (in the promoter of the neo
cassette).
Primers wdb and wrb amplify a 560 bp product specific for the wt allele;
whereas the primers wdb and krb amplify a 455 bp product specific for the
mutated allele.
In the case of Pax8Cre/+ mice the genotyping was performed as previously
described (Bouchard et al 2004).
TgCRE transgene was identified using the following primers:
k7: 5’-AGTCCCTCACATCCTCAGGTT (in the CRE coding sequence)
K8: 5’-ATGCCAACCTCACATTTCTTG (in the CRE coding sequence)
that amplify a 450 bp product specific for CRE.
PCR setup
All PCR reactions were conducted using 100-500 ng of genomic DNA,
1xBuffer (10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2) 2 µM of
common primer, 1µM of each specific primer, 200 µM of each dNTP, and 0.5
units of Taq polymerase in a final volume of 25L. Reactions were performed
with the following cycling parameters: 35 cycles of 95°C for 1 min, 58°C for 1
min and 72°C for 1 min.
The PCR products were analyzed by agarose gel electrophoresis.
Agarose gel electrophoresis
The PCR products were analyzed by agarose gel electrophoresis. The agarose
gels were cast by melting the agarose in TAE buffer (40 mM Tris-Acetate pH
7.5, 1 mM EDTA) with the addition of the fluorescent dye ethidium bromide to
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a final concentration of 0.5 μg/ml. The percentage of agarose in gels was
determined depending on the size of DNA fragments to be resolved. Gels were
generally run at 90V in 1" TAE buffer and DNA bands were visualized on UV
transilluminator.
3.5 Histology, immuno-histochemistry and immuno-fluorescences
Mouse embryos at specific developmental stages were obtained from pregnant
females, which were sacrificed by cervical dislocation. Thyroid glands were
dissected from embryos or adult mice. Thyroids and embryos were fixed
overnight at 4°C in 4% paraformaldehyde (PFA) in phosphate-buffered saline
(PBS), pH 7.2, dehydrated through higher grades of alcohol, cleared in xylene,
embedded in paraffin blocks and 7!m sections were cut. For histological
examinations, serial paraffin sections from DHTP and wild type mice were
stained with Harris hematoxylin and aqueous eosin (BDH Laboratory Supplies)
or with periodic acid-Schiff reagent-PAS (Sigma) according to the standard
protocols.
For immunohistochemical and immunofluorescences studies, paraffin sections
of embryos and thyroids were dewaxed in xylene, hydrated through decreasing
ethanol grades, washed twice in PBS and once in PBS, 0.2% Triton. To inhibit
the endogenous peroxidases, the sections were treated with 0.5% H2O2 in
absolute methanol for 15 min at RT. Unmasking of the antigen sites was
necessary by performing heat treatment of the sections in citrate buffer (0.01
M, pH 6.0). After washes in PBS, the sections were incubated in a humid
chamber with histoblock solution (3%BSA, 5% NGS, 20 mM, MgCl2, 0.3%
Tween 20 in PBS, pH 7.2) for one hour at RT to prevent nonspecific staining
and further incubation with the primary antibodies was carried out over night at
4°C.
The follow rabbit polyclonal primary antibodies were used:
- anti-Pax8 0,87µg/mL
- anti-Titf1 0,6 µg/mL
- anti-Nis 1:2000 (Dako)
- anti-Tg 0.096 µg/mL
- anti-Calcitonin 1:2000 (Dako)
- anti-Ki67 1:800 (Epitomics)
The incubation with the secondary antibodies was for 1 hour at RT.
The follow anti-rabbit secondary antibodies were used:
-biotinylated anti-rabbit IgC 1:200 (Vector) for the immunihistochemistry
-fluorescein anti-rabbit IgC (Vector) for the Immunofluorescences.
In the immuno-histochemistry, the immunoperoxidase system of the
“Vectastain ABC kit” (Vector) was used, and the detection was performed
using the “DAB substrate kit for peroxidise” (Vector), according with the
manufacturer’s protocol. The reaction was controlled under microscope and
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stopped in tap water, dehydrated in graded alcohols, cleared in xylene and
mounted in EUKITT reagent (BDH).
In the Immunofluorescences experiments, the sections were incubated  with
DRAQ5 1:1000 (for the nuclei staining) and the slides were mounted with a
solution glycerol/PBS1x 1:1, containing Hoechst.
3.6 Hormone measurements
Keeping the mice under light anaesthesia, blood samples from their tail veins
were collected in eppendorf tubes without the presence of anticoagulant. After
coat formation the samples were centrifuged and the recovered sera were kept
frozen at -20°C until assayed.
TSH levels were determined by ELISA assay using the “Rat TSH ELISA Kit”
(Gentaur), following the manufacturer’s protocol.
3.7 RT-PCR and Quantitative Real-time PCR
Total RNA was extracted from thyroids using the “TRIzol” reagent
(Invitrogen), and 1 µg was used as template for the synthesis of the first reverse
cDNA strand by using the “QuantiTect Reverse Transcription” kit (Quiagen),
according with the manufacturer’s procedures.
RT-PCR
The RT-PCR performed to screen the Cre-mediated recombinant Pax8
transcript was carried out using 50 ng of cDNA and the following primers:
RTf1: 5’- GCCTCACAACTCGATCAGATCC
RTr1: 5’- TCAGTGTGTGTCCTGGGCTCA
Real-time PCR
I calculated preliminarily, the amplification efficiency of each primer pairs
using cDNA standard dilution series as reported (Rutledge and Cote 2003).
RT-PCR amplifications were conducted using 12,5μl of Power SYBR Green
PCR master mix (Applied Biosystem), 0.3 μM of each primers a final volume
of 25μl. Thermocycling was performed using ABI Prism 7900 Real Time PCR
System (Applied Biosystems Foster City, USA). Ct (threshold cycle) values
were determined by Applied Biosystems software and analyzed using MS
Excel program. For each primer-pair, I generated a standard curve plotting the
resulting Ct values against corresponding cDNA dilution series. The slope of
the curve was used to calculate the amplification efficiency.
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Reactions for quantification of mRNAs were performed in the same conditions
as described above, using 20ng of cDNA as a template. The expression of the
gene of interest is normalized for the expression of Abelson gene measured
under the same condition considering the amplification efficiency of each
primer pairs. For each genotype, the data obtained, express as arbitrary units,
represent the mean of three independent samples.
The couples of primers used to quantify  the several genes analyzed are the
following:
Pax8Fw1:    5’-GCCATGGCTGTGTAAGCAAGA (EX3)
Pax8Rev1:   5’-GCTTGGAGCCCCCTATCACT (EX4)
Pax8Fw2/5: 5’-CAGTGTCAGCTCCATCAACAGAAT (EX2/5)
Pax8Fw: 5’-AGTGCAGCAGCCATTCAAC (EX5)
Pax8Rev6: 5’-CTGGGGGTGTTACAGCTGAG (EX6)
Titf1Fw:      5’-CTACTGCAACGGCAACCTG
Titf1Rev:     5’-CCCATGCCATCATATATTCAT
TgFw:          5’-CATGGAATCTAATGCCAAGAACTG
TgRev: 5’-TCCCTGTGAGCTTTTGGAATG
TpoFw: 5’-CAAAGGCTGGAACCCTAATTTCT
TpoRev: 5’-AACTTGAATGAGGTGCCTTGTCA
NisFw: 5’-TCCACAGGAATCATCTGCACC
NisRev: 5’-CCACGGCCTTCATACCACC
AblFw: 5’-TCGGACGTGTGGGCATTT
AblRev: 5’-CGCATGAGCTCGTAGACCTTC
BclFw: 5’-AGTACCTGAACCGGCATCTG
BclRev: 5’-CATGCTGGGGCCATATAGTT
TshFw: 5’-TCCCTGAAAACGCATTCCA
Tshrev: 5’-GCATCCAGCTTTGTTCCATTG
3.8 Array hybridization and data analysis
The embryonic thyroid glands were dissected 1-d-old mice and three samples
were pooled for each genotype. Total RNA was extracted with TRIzol. 100 ng
of total RNA was processed to generate cRNA by using the Affymetrix One-
Cycle Target Labeling and Control Reagent kit (Affymetrix Inc., Santa Clara,
California, USA), following the manufacturer’s protocol.
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The biotinylated cRNA was fragmented and hybridized to the MOGENE 1-0-
ST-V1 Affymetrix DNA chips, containing 28815 probesets. Chips were
hybridized at 42°C for 16 hours in rotation to ensure mixing, washed and
exposed to R-phycoerytrin conjugated streptavidin to evidentiate hybridized
biotinylated cRNA. Then they were scanned on the Affymetrix Complete
GeneChip Instrument System at a 3μm resolution, generating digitalized image
data (DAT) files. The reactions were carried out in triplicate.
DAT files were analyzed with AGCC (Affymetrix, Santa Clara, CA) producing
CEL files. RMA normalization and data analysis was performed using
GeneSpring 10.1 (Agilent Technologies, Santa Clara, CA).
We consider for the further analysis a probeset if it’s expression overcome the
20th percentile in the whole chip distribution in at least 2 of the 3 replicates
and in 1 of the 2 conditions.  Under this conditions only 25056 probesets are
used in the further analysis.
Differentially expressed (DE) genes between Pax8Cre/fl and Pax8Cre/+ thyroids
were selected on the basis the fold change (the ratio between the expression
levels in the two samples) and on the T-test, using as p-value a cut off of 0.05.
3.9 Administration of Tamoxifen
Tamoxifen (Sigma) was dissolved in a sunflower oil/ethanol (9:1) mixture at
10mg/mL. In mice at 4 weeks, 50mg/kg tamoxifen were injected every 12
hours for 5 days. One week to three months depending on the experiments,
mice were sacrificed and their thyroid dissected.
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4.  RESULTS AND DISCUSSION
4.1 Generation of a conditional allele of the Pax8 gene
To generate a Pax8 conditional knock-out mouse strain, a targeting vector
containing two loxP sites in the same orientation was constructed. The figure
13 shows a schematic representation of the wild-type Pax8 allele, of the
targeting vector used to modify it and the Pax8 allele after homologous
recombination, together with the corresponding flipped and deleted products.
In the targeting vector the positions of the two loxP sites and of the neomycin-
resistant cassette are reported. The first loxP site was inserted in the intron 2 of
the Pax8 gene, and the second loxP, together with the neomycin-resistant
cassette flanked by an FRT site at each end, was inserted in the intron 4; in this
way, after a Cre-mediated recombination, we have the depletion of the exons 3
and 4, that codify for the DNA binding domain, with consequent synthesis of a
non-functional protein.
Wild-type Pax8 allele
Targeted Pax8 allele
Flipped Pax8 allele
Deleted Pax8 allele
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1 2 4 5 6 7 8 9
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ScaI
ScaI ScaI ScaI
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FLP-mediated
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(in vitro)
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Figure 13 Generation of the Pax8-floxed mouse. Diagram of the Pax8 gene (wild-type allele), targeting
vector, targeted allele, flipped allele and deleted allele. The flipped allele is the product of the FLP-
mediated recombination between the FRT sites in the ES cells; the deleted Pax8 allele is the product of
the Cre-mediated recombination between the loxP sites in mice. The coding regions of the gene are
indicated by solid boxes. The neomycin cassette is represented by an open box marked with pGK-Neo.
The loxP and FRT sites are shown by solid triangles and shadow boxes, respectively. The ATG and the
restriction enzyme used for the Southern strategy are indicated.
To generate the construct, I used the recombineering method (also known as
Red/ET recombination), a technique that allows for the insertion, deletion, or
mutation of DNA sequences, assuaging the need for conveniently located
restriction sites.
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The process of generating the Pax8 conditional knock-out targeting vector
consisted of three main steps (as described in Material and methods):
4) retrieval of genomic region of interest from a bacterial artificial
chromosome (BAC) onto targeting vector  backbone by gap repair;
5) insertion of an orphan loxP site;
6) insertion of FRT-Neo-FRT-loxP cassette with the same orientation of the
orphan loxP site.
The targeting vector DNA was linearized and electroporated in R1 ES cells. To
select the clones in which the construct was incorporated in the genomic DNA,
the cells were grown in presence of the G418 antibiotic. 300 ES clones were
picked and expanded, and their DNA was extracted and analyzed by
polymerase chain reaction (PCR).
In figure 14a a schematic representation of the wild-type and targeted Pax8
alleles is shown, with the primers used for the PCR screening indicated with
red arrows. In order to discriminate the homologous recombinant clones from
the non recombinant ones, the primers (F1/R1 in the scheme) amplify the
genomic region going from the intron 2 to the exon 5.  Using this strategy, I
obtained two different products, a 7500 bps band corresponding to the
amplification of the wild type (wt) allele, and a 9500 bps band corresponding
to the amplification of the recombinant allele,
Figure 14b shows the result obtained in the  screening  of the ES clones; 11
out of 300 ES cells screened  turned out to be homologous recombinants.
To  further validate the results obtained with the first screening, another PCR
was performed using the oligonucleotides NeoR and F1 (see Fig. 14c)
confirming the genotype of the positive clones.
Finally, in order to check if any undesired  random integration event occurred
in the selected clones, I performed a Southern blotting; as shown in figure 14d,
both wild-type and the recombinant bands are present in the targeted ES clone,
while the wild type control only shows the 18600 bp band.
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Figure 14 Screening of recombinant ES cells. (a) Diagram of the Pax8 wild-type and targeted allele, the
primers used for the screening are indicated; (b) PCR analysis of the ES cells performed with the couple
of primers F1/R1 (expected bands: 7500bp wt allele, 9500bp recombinant allele), the positive clones are
in the red frame; (c) PCR analysis of the ES cells performed with the F1/NeoR (expected band: 8500bp);
(d) Southern blotting analysis (expected bands: 13600bp recombinant allele, 18600bp wt allele). Solid
boxes indicate the coding regions of the gene. An open box marked with pGK-Neo represents the
neomycin cassette. The loxP and FRT sites are shown by solid triangles and shadow boxes, respectively.
The primers used for the PCR screenings and the Southern probe are indicated by red arrows and red thin
lane, respectively. The ATG and the restriction enzyme used for the Southern strategy are indicated.
To remove the neomycin-resistance cassette, one of the clones was transfected
with an FLP-expressing plasmid (see Materials and Methods). 24 clones were
picked and grown in absence of the G418. Then DNA was extracted and the
FLP-mediated site-specific recombinants were screened by PCR.
In figure 15a a diagram of the wild type, targeted and flipped Pax8 allele are
reported: the primers used for the flipped clones screening (F3/R3) are
annotated as red arrows. Using these primers, I amplified a 150 bp band on the
wild-type allele, a 260 bp fragment on the site-specific recombinant allele and
a 2100 bps band on the non-recombinant allele. The panel in figure 15b shows
the PCR results. By this screening, I found that 80% of the picked clones were
positive for the FLP-mediated recombination.
One flipped ES clone was injected into a C57BL/6 blastocyst, from this
injection three chimeric male were born with a chimerism degree higher than
70% and they were bred with C57BL/6 females to generate heterozygous loxP
targeted/wild-type mice (Pax8fl/+). These mice were screened by PCR using a
couple of primer (Int2F/Pa1R in figure 15a) designed at the ends of the
insertion point of the orphan loxP. With this strategy I obtain a 300 bp band,
that identifies the wt allele, and a 395 bp band, resulting from amplification of
the floxed allele, longer than the wt band because of the loxP site insertion.
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The picture 15c represents the analysis carried out on DNA extracted from tail-
biopsies. Pax8fl/+ mice are viable and healthy and follow the expected
mendelian ratio.
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Figure 15 Screening of flipped ES clones and germ line transmission. (a) Diagram of the Pax8 wild
type, targeted and flipped allele, the primers used for the screening PCR are indicated as red arrows; (b)
PCR analysis on the Flp-mediated recombinant clones to remove the neomycin-resistant cassette
(expected bands: 260 bp flipped allele, 150 bp wt allele), lanes 1-3 recombinant clones, lane 4-5 wild-type
DNA, lane 6 blank; (c) PCR analysis on  tail-extracted DNA of mice born from chimera crossed with
females C57BL/6 (expected bands: 395 bp floxed allele, 300 bp wt allele), lane 1-4 heterozygous mice
Pax8fl/+, lane 5 wt  DNA, lane 6 ES positive clone DNA, lane 7 blank. Solid boxes indicate the coding
regions of the gene. An open box marked with pGK-Neo represents the neomycin cassette. The loxP and
FRT sites are shown by solid triangles and shadow boxes, respectively. The length of the PCR products is
indicated with green arrows.
4.2 Cre-mediated recombination of floxed Pax8 allele: deletion of the
floxed Pax8 allele mediated by Pax8-Cre (strain Pax8Cre/fl)
To selectively drive the deletion of the Pax8 allele in the thyroid gland,
heterozygous mice for the floxed Pax8 allele (Pax8fl/+) were bred with the
Pax8Cre/+ knock-in mice (Bouchard et al. 2004), described in the paragraph
1.4.1. This breeding scheme generated mice with the following genotypes:
Pax8+/+, Pax8+/Cre, Pax8+/fl and Pax8Cre/fl (Fig. 16).
Since the Cre-driver strain used for these experiments is a knock-in with the
recombinase inserted in the Pax8 endogenous locus, one recombination event
per cell is sufficient to completely delete every Pax8 function.
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Figure 16 Breeding scheme between the heterozygous mice for the floxed Pax8 allele and the
heterozygous mice for the Pax8-Cre allele. The coding regions are represented by boxes, grey for Pax8
and orange for Cre; the exons are numerated. The solid triangles indicate the loxP sites.
To confirm that Cre-mediated recombination occurred in the floxed Pax8 allele
in vivo, a result of exons 3 and 4 deletion, a RT-PCR (see MATERIALS AND
METHODS) was carried out using thyroids obtained from embryos at
embryonic day (E) 16.5 and 17.5. As illustrated in the scheme of the figure
17a, for this experiment a couple of primers was designed to amplify the
transcript region extending between the exons 2 and 5, in order to generate
two different PCR products: a shorter band on the  recombinant transcript and a
longer fragment on the wild type.
In figure 17b and c it is represented a correct recombination between the two
loxP sites: as shown by RT-PCR results, the 476 bp band (wt band) is still
present at E16.5, indicating that the recombination is not complete, while at
E17.5  the wild type band becomes very faint.
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Figure 17 Cre-mediated recombination in embryonic  thyroids. (a)  The primer RTf1 recognizes the
exon 2 and the primer RTr1 the exon 5; the expected bands were of 476 bps on the wt transcript and 112
bps on the recombinant one. The coding regions are represented by grey boxes, loxP sites by solid
triangles; (b) RT-PCR performed on thyroids collected from embryo E16.5; (c) RT-PCR performed on
thyroids collected from embryo E17.5. Green and red arrowheads, indicate wt and recombinant products,
respectively. The 300bp band, black arrowhead, is a non-specific product in the PCR reaction due to the
presence of the Pax8-Cre allele.
4.2.1 Thyroid morphogenesis in Pax8Cre/fl mice
Since Pax8 is expressed by E8.5, I decided to analyze thyroid development in
Pax8Cre/fl mice. Embryos at the stages of E12.5 and E14.5, obtained from
crosses of Pax8fl/+ with Pax8Cre/+ mice, were collected and analyzed.
The panel in figure 18 shows hematoxylin-eosin staining of histological
sections from Pax8Cre/fl, Pax8Cre/+ and Pax8+/+ embryos at the stage of E12.5 and
E14.5. At both stages, the histological analysis reveals that developing thyroid
is comparable in size  and shape in all the genotypes.
Results and Discussion
40
E12.5
E14.5
Pax8Cre/fl Pax8Cre/+
20x
20x 20x
20x
a b
d
Pax8+/+
20x
20x
c
e f
Figure 18 Hematoxylin and Eosin staining on sagittal paraffin-embedded sections of E12.5 and
E14.5 embryos. (a-c) H&E staining on E12.5 Pax8Cre/fl, Pax8Cre/+ and Pax8+/+ embryos, respectively. The
developing thyroid is indicated with a dashed circle;  (d-f) H&E staining on E14.5 Pax8Cre/fl, Pax8Cre/+ and
Pax8+/+ embryos, respectively. The size of the developing thyroid in Pax8cre/fl embryos is  not different
from that of the control embryos.
Afterwords, we analyzed the expression of thyroid-specific markers, such as
Titf1 and  Thyroglobulin (Tg), that starts to be detectable at the embryonic
stage of 14.5. As figure 19 shows, both proteins were comparably expressed in
the Pax8Cre/fl developing thyroid  and the controls.
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Figure 19 Titf1 and Tg immunostaining on sagittal paraffin-embedded sections of E12.5 and E14.5
embryos. The antibodies used and the embryonic stage and the genotype of the samples analyzed are
indicated. Both Titf1 (a-f) and Tg (g-i) expression are unaltered in the two samples.
All together, these data suggest that during embryonic development the Cre-
mediated deletion of the floxed allele could not be sufficient to impair thyroid
morphogenesis. To determine whether Pax8 was still expressed in developing
thyroid, I performed an immuno-histochemistry on embryo sections at the
stage of E12.5 and E14.5: as shown in figure 20, Pax8 levels appears not to be
affected. Hence, the lack of the phenotype is due to an inefficient deletion of
Pax8.
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Figure 20 Pax8 immunostaining on sagittal paraffin-embedded sections of E12.5 and E14.5
embryos. The embryonic stage and the genotype of the samples analyzed are indicated. Pax8Cre/fl
embryos did not show differences in Pax8 expression.
From this analysis we can conclude that, despite the recombinase in the Pax8-
Cre mice starts to be expressed at the embryonic stage of 8.5, its expression
levels are probably not sufficient to mediate the recombination in the majority
of the thyrocytes during gland organogenesis. These data are consistent with
the finding that Pax8 Cre-mediated recombination in developing kidney
appears to be discontinuous and inefficient, particularly in heterozygous
Pax8Cre/+ mice (Bouchard et al 2004)
4.2.2 Analysis of the structure and function of the thyroid in Pax8Cre/fl mice
To check whether Cre-mediated recombination between the loxP sites was
complete in the 1-month-old Pax8Cre/fl mice, I performed RT-PCR, as
previously described in paragraph 4.2 (Fig. 21). This analysis showed that in
the mutant samples the wild-type band has completely disappeared (476 bp).
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Figure 21 Cre-mediated recombination in 1-month-old thyroids. (a) The primer RTf1 recognizes the
exon 2 and the primer RTr1 the exon 5; the expected bands were of 476 bps on the wt transcript and 112
bps on the recombinant one; (b) RT-PCR performed on thyroids collected from 1-month-old mice. The
wild-type band is completely disappeared in the Pax8Cre/fl cDNAs. The coding regions are represented
by grey boxes, loxP sites by solid triangles. Green and red arrows indicate wt and recombinant products,
respectively. The 300bp band, black arrowhead, is a non-specific product in the PCR reaction due to the
presence of the Pax8-Cre allele.
To confirm that the expression of Pax8 was down-regulated, I carried out a
real-time PCR (see Materials and Methods). The couple of primers used for
this experiment were designed at the exons 3/4 junction, to selectively amplify
only the non-recombinant allele. I performed this experiment on pools of RNA
extracted from the thyroid of three different 1-month-old mice for each
genotype, and the results are represented in the graph of the figure 22. This
analysis revealed that in the Pax8Cre/fl mice Pax8 transcript is strongly reduced
compared both to the wild-type and the heterozygous for the Pax8-Cre allele
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Figure 22 Real-time PCR performed to quantify the wild-type Pax8 transcript. The cDNAs used for
this experiment were retro-transcribed from pools of RNAs extracted from  the thyroids of 5 1-month-old
mice for each genotype. Two different Pax8Cre/fl pools were used and in both sample the Pax8 expression
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is almost undetectable. The Pax8Cre/+ mice are characterized by reduced  Pax8 levels respects to the wild
type since they have only a copy of the gene.
Thyroid function
Mice born from crosses of Pax8fl/+ and Pax8Cre/+ lines respects the mendelian
ratio.
One month after  birth, Pax8Cre/fl mice appear smaller then their littermates
(Fig. 2a). A comparison of body weight of these mice showed that there are
statistically significant differences between the conditional knock out and the
wild-type mice (Fig. 23 b, c), while Pax8Cre/+, Pax8fl/+, Pax8+/+ body weights are
comparable.
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Figure 23 Body weight graphs of the 1-month-old mice born from crosses of Pax8fl/+ and Pax8Cre/+
lines. (b,c) Each point represents a value for a single mouse.
The tables show mean, s.d, minimum and maximum values for each genotype.
*** = p < 0.001 Pax8Cre/fl versus wt or single heterozygous mice by unpaired, two tailed Student’s t test.
Since the adult body weight is a physiological parameter under the control of
thyroid hormons, postnatal growth defects can be associated with a deficiency
in thyroid gland function.
TSH level is considered to be a critical indicator of the severity of the pituitary-
thyroid axis dysfunction (Murray D 1998): thus I decided to investigate the
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thyroid functionality by measuring TSH serum levels through an ELISA assay
(see Materials and Methods) performed on the blood serum of 5 different 1-
month-old mice for each genotype.
The results, reported in figure 24, show that Pax8Cre/fl mice have a mean serum
TSH concentration 4-fold higher that the control samples, while the results
obtained for the Pax8Cre/+, Pax8fl/+, and Pax8+/+ mice are comparable.
Pax8Cre/fl Pax8Cre/+ Pax8+/fl Pax8+/+
Figure 24 Serum TSH levels in Pax8Cre/fl, Pax8Cre/+, Pax8fl/+ and Pax8+/+ 1-month-old mice. For each
genotype, 5 different samples were analyzed.
Taken together, these findings demonstrate that the Pax8Cre/fl mice are affected
by a severe hypothyroidism, since their thyroid is not able to secrete a
sufficient amount of hormones.
Thyroid structure
To analyze the structure of the thyroid gland, we dissected the thyroids from 1-
month-old Pax8Cre/fl, Pax8Cre/+ and Pax8+/+ mice.
As figure 25 shows, in Pax8Cre/fl mice the thyroid gland is remarkably smaller
compared to control thyroid from either wild-type or Pax8Cre/+ mice (panel 25
a-c). Moreover, histological analysis indicates that the follicular structure of
Pax8Cre/fl thyroid is strongly impaired and it is not possible to distinguish any
follicular structures (panel 25 e-f).
All the experiments performed until this point demonstrate that in Pax8Cre/+
mice both thyroid structure and thyroid function are similar to those of wt mice
(Fig. 24-25). Furthermore, immuno-histochemistry assays (data not shown)
demonstrate that Titf1, Foxe1 and Tg are expressed at comparable levels in
both the murine lines.
Hence, from now on, only Pax8Cre/fl mice were compared with Pax8Cre/fl mice.
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Figure 25 Morphology and histology of 1-month-old thyroids. The Pax8Cre/fl (a) thyroid is smaller that
the controls (b-c). (d-i) Hematoxylin-eosin staining of sagittal paraffin-embedded thyroid sections; the
Pax8Cre/fl (d,g) sections have lose the follicular structure typical of the normal glands (e,f,h,i).
4.2.3 Molecular phenotype of thyroid in Pax8Cre/fl mice: gene expression
analysis
Several genes encoding proteins involved in the thyroid hormone biosynthetic
machinery have been proposed to be under the control of Pax8 (Damante et al.
2001). To investigate whether the decreased levels of this transcriptional factor
affects the expression of thyroid-enriched genes, such as thyroglobulin (Tg),
thyroperoxidase (TPO), TSHR, NIS and Titf1, mRNA levels of these genes
were analyzed with a quantitative RT-PCR performed on RNA extracted from
1-month-old Pax8Cre/fl and Pax8Cre/+ thyroids.
The panel in figure 26 shows that, compared to the control, the expression
levels of Tg, TPO, NIS and TSHR were significantly reduced in Pax8Cre/fl,
while Titf1 transcription levels not are significantly affected by Pax8
inactivation.
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Furthermore, recent data from our lab (Fagman et al. in press) have confirmed
that, in vivo, Pax8 regulates the expression of Blc2, as already reported in cell
line (Hewitt et al. 1997). Hence we decide to analyze the expression of Bcl-2
too, whose expression, as shown in figure 26, is reduced in Pax8Cre/fl mice.
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Figure 26 Real-time PCR of thyroid-specific genes in Pax8Cre/fl and control thyroids. For each
genotype, the data represent the mean of three independent samples, each representing RNA pooled from
three 1-d-old thyroid. The amount of transcript in the samples is expressed in arbitrary units as the ratio
between the amount of sample and the amount of Abelson transcript, the endogenous control. In Pax8Cre/fl
mice, the expression of Tg, Tpo, Nis, Tshr and Bcl-2 appears significantly affected by the deficiency of
Pax8.
To validate the data obtained from the quantitative analysis performed by real-
time PCR, an extensive immuno-histochemistry analysis was carried out using
serial sections of whole thyroids.
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Figure 27 Immunostainings on serial thyroid paraffin-embedded sections of 1-month-old Pax8Cre/fl
and Pax8Cre/+ mice. The antibody used and the genotype of the samples analyzed are indicated. In
Pax8Cre/fl thyroids sections (a-d) only the transcription factor Titf1 is detectable, while the other markers,
clearly visible in control samples (e-h), are undetectable.
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Figure 28 Immunofluorescent staining of Nis in Pax8Cre/fl and Pax8Cre/+ DAPI staining was used for
the detection of the nuclei. The merge between the two probes is shown. The typical NIS signal is clearly
visible on the baso-lateral membrane of the Pax8Cre/+ thyrocytes (e,f), while in the Pax8Cre/fl thyroid(b,c)
any signal is detectable .
Figures 27 and 28 show 1-month-old Pax8Cre/fl and Pax8Cre/+ thyroid sections
stained with Pax8, Tg, Foxe1, Titf1 and NIS antibodies. All these proteins
seem to be strongly down-regulated (Fig. 27 a,b,c, Fig. 28 b) except for Titf1
(Fig. 27 d) where is still possible to distinguish many  nucleus stained for this
protein, even if the follicular structure is impaired.
From the results of the real-time PCR and immunostaining experiments we
assume that Pax8 is not expressed and many genes usually expressed in thyroid
differentiated cells are down-regulated exception made for Titf1 whose
expression seems not to be affected.
In thyroid gland, calcitonin-producing cells (C-cells) coexist with thyroid
follicular cells and, although different from follicular cells in function and
embryological derivation, also express Titf1 (Suzuki et al. 1998). For this
reason I wandered if Titf1-positive cells present in Pax8Cre/fl thyroid were
follicular cells or calcitonin cells. To answer this question, serial sections of a
Pax8Cre/fl thyroid were stained with anti-calcitonin and anti -Titf1 antibodies.
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As the figure 29 shows, Titf1 positive cells are distributed in all the section,
but the calcitonin signal is localized only in restricted areas.
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Figure 29 Comparison between Titf1- and Calcitonin-stainings of serial paraffin-embedded thyroid
sections of Pax8Cre/fl 1-month-old mice. (a) Titf1-positive nuclei are uniformly distributed  on the
section, while the calcitonin signal is localized only in restricted area of the thyroid (b). This finding
indicates  that a large part of Titf1 positive cells are not C-cell.
These results were confirmed on thyroids isolated from different mice.
Taken together, these findings confirm that in vivo Pax8 plays an important
role in the maintenance of the thyroid differentiated phenotype, by regulating
the expression of genes like TG, TPO, NIS and TSHR, that are essential for the
gland physiology (Ohno et al. 2004, Pasca di Magliano et al. 2000, Fabbro et
al. 1998), and of Foxe1, that was already suggested to be a Pax8 downstream
target (Parlato et al. 2004).
4.2.4 Global gene expression profile in Pax8Cre/fl thyroid mice
To define the entire spectrum of changes in gene expression related to the
inactivation of the Pax8 gene, I decided to analyze the global gene expression
profiles in thyroid dissected from Pax8Cre/fl and Pax8Cre/+ mice. Since I was
interested to investigate the early effect of Pax8 absence, preliminarily I
analyzed the time course of Pax8  down-regulation. To this aim, I collected
Pax8Cre/fl and Pax8Cre/+ thyroids at several embryonic stages, E18.5, 1 day and 2
weeks after birth, and I evaluated the total amount of Pax8 transcribed by real
time PCR (data not shown). Finding that in 1-d-old mutant mice Pax8
expression was already completely absent. According to this experiment I
chose to analyze the global transcriptome in 1-d-old Pax8Cre/fl thyroids.
RNAs from Pax8Cre/fl and Pax8Cre/+ were pooled and analyzed, using the
Affimetrix mouse expression set MOGENE 1-0-ST-V1 GeneChips covering
28,815 mouse transcripts. For each genotype, three independent RNA samples
were used, each representing RNA pooled from three thyroids. Statistically
significant differences in the levels of gene expression between conditional
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knock-out and control samples were identified with values of P ≤ 0.05 and fold
changes ≥ 1.5.
25,056 transcripts had a detectable expression in thyroid.
In figure 30 a hierarchical clustering of the differentially regulated genes is
shown in two-dimensional matrix.
Pax8Cre/flPax8Cre/+
Figure X30 Two dimensional hierarchical clustering. Data from MOGENE 1-0-ST-V1 Affimetrix
chips identifying mRNAs significantly regulated in Pax8Cre/fl thyroids in comparison with the control are
shown. Intensity in the red and green range indicates the increase and decrease in mRNA abundance,
respectively. Each row represents a single gene; each column represents a particular experimental sample;
each box represent a normalized gene expression value.
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Considering the high number of transcripts found expressed  in the thyroid,
only 58 genes appear to be modulated in Pax8Cre/fl compared with Pax8Cre/+ of
the same age. 39 out of 58 are  already  known to be expressed in thyroid as
reported in tables 1 and 2.
Because of the restricted number of genes, analysis based on either Go
Classification or Ingenuity Pathway Analysis (IPA), directed to find their most
significant biological functions, did not produce reliable results. So, we
decided to characterize the list of genes according to their biological function
as reported in the scientific literature.
This rough analysis strongly suggested that these differentially expressed genes
are functionally correlated.
Among the  up regulated genes,  the top seven are implicated, directly or
indirectly, in cell death pathway. In particular, Car3 (Carbonic anhydrase) may
act as a member of the immune system against oxidative stress (Kim et al.
2004); cytochrome oxidases, (Cox8b and Cox7a1) stimulate caspase activation
via cytochrome c oxidation (Borutaite and Brown 2007); Lipocalin-2, which
binds or transports lipid and other hydrophobic molecules, is considered a pro-
apoptotic protein (Kehrer 2010); GPC3 inhibits the PI3K/Akt anti-apoptotic
pathway (Buchanan et al. 2010); Lgals1 (Galectin-1) and Fstl1  are known to
promote the apoptosis (Motran et al. 2008, Chan 2009). It is worth noting that
the anti-apoptotic gene Bcl2 was down regulated  as previously demonstrated
by Real Time PCR experiments (see Fig. 26).
Pro-apoptotic genes up-regulation and anti-apoptotic genes down-regulation
suggests a shift toward apoptosis which fits with the observed morphological
phenotype of the thyroid in  Pax8Cre/fl mice.
The most down-regulated genes are Tg and TPO; several studies in cell lines
proved that expression of both these genes is regulated by Pax8 (Pasca di
Magliano et al. 2000, Fabbro et al. 1998). Another well known Pax8 target,
NIS (Ohno et al. 2004), is not included in the present list probably due to its
low expression levels; however, data presented in figure 26 and figure 28
clearly indicate that this protein is absent in Pax8Cre/fl mice.
Other down-regulated genes identified have not yet been described  as a target
of Pax8. Atp1b1 encodes for the beta subunit of Na+/K+-ATPases localized on
the basolateral membranes of thyroid follicular cells; the electrochemical
sodium gradient generated by the Na+/K+-ATPases is required to drive the
NIS-mediated transport of iodide. Kcnip3 (DREAM) modulates the
transcriptional activity of Titf1 (D'Andrea et al. 2005). CD24, a polypeptide
molecule is supposed to play a role in the thyroid regenaration (Chen et al.
2009). Prlr, prolactin receptor,  is detected in normal and neoplastic human
thyroid tissues as well as in the developing thyroid (Fagman and Di Lauro,
personal communication); its role in thyroid is still unknown.
Dcpp1 and Dcpp2 genes encode for demilune cell and parotid protein 1 and 2
respectively; interestingly, Dcpp shows a 70-fold up-regulation in thyroid from
transgenic mouse over-expressing the Adenosine Receptor 2a (Goffard et al.
2004).
Results and Discussion
53
Table 1 Genes down-regulated in Pax8Cre/fl thyroid versus Pax8Cre/+ thyroid
Gene  name Description Expressed in thyroid* Fold change
Tg Thyroglobulin Yes 7,2
Tpo Thyroid peroxidase Yes 5,6
Dcpp3 Demilune cell and parotid
protein 3
1,2 3,4
Atp1b1 ATPase, Na+/K+
transporting, beta 1
polypeptide
Yes 3,3
Dcpp1 Demilune cell and parotid
protein 1
1,2 3
Cd24a CD24a antigen Yes 3
Dcpp2 Demilune cell and parotid
protein 2
1,2 3
Kcnip3 Kv channel interacting
protein 3, calsenilin
Yes 2,9
Prlr Prolactin receptor Yes 2,4
Nfkbia Nuclear factor of kappa
light polypeptide gene
enhancer in B-cells
inhibitor, alpha
Yes 2,3
1600029D21Rik placenta-expressed
transcript 1 protein
precursor
Yes 2,2
Slc26a7 Solute carrier family 26,
member 7
Yes 2,2
Slc16a2 Solute carrier family 16
(monocarboxylic acid
transporters), member 2
Yes 2,2
Cybrd1 Cytochrome b reductase 1 Yes 2,2
Kcnk1 Potassium channel,
subfamily K, member 1
Yes 1,97
Cdk8 Cyclin-dependent kinase
8
Yes 1,9
Vegfa Vascular endothelial
growth factor A
Yes 1,8
Ceacam1 CEA-related cell
adhesion molecule 1
Yes 1,8
Emcn Endomucin Yes 1,7
Ces3 Carboxylesterase 3 Yes 1,7
Txnip Thioredoxin interacting
protein
Yes 1,7
Timp3 Tissue inhibitor of
metalloproteinase 3
Yes 1,7
Rbpms RNA binding protein
gene with multiple
splicing
Yes 1,7
Bmp5 Bone morphogenetic
protein 5
1 1,5
Slc4a5 Solute carrier family 4,
sodium bicarbonate
cotransporter, member 5
Yes 1,5
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B2m Beta-2 microglobulin Yes 1,5
Genes which decreased in expression at least 1,5-fold with p-values  0.05 are reported.
*according to EST database (http://www.ncbi.nlm.nih.gov/nucest)
1 Burniat A et al., 2008, according to UniGene (http://www.ncbi.nlm.nih.gov/unigene)
2 Su AI et al., 2002, according to UniGene (http://www.ncbi.nlm.nih.gov/unigene)
Table 2 Genes up-regulated in Pax8Cre/fl thyroid versus Pax8Cre/+ thyroid
Gene  name Description Expressed in thyroid* Fold change
Car3 Carbonic anhydrase 3 Yes 5,5
Cox8b Cytochrome c oxidase,
subunit VIIIb
1 4,5
Lcn2 Lipocalin 2 1 2,3
Cox7a1 Microfibrillar associated
protein 5
1 2,3
Gpc3 Glypican 3 1 2,2
Fstl1 Follistatin-like 1 Yes 2,2
Lgals1 Lectin, galactose binding,
soluble 1
Yes 2,1
Scd1 Stearoyl-Coenzyme A
desaturase 1
Yes 2,1
Osr1 Odd-skipped related 1 1 2,1
Dbi Diazepam binding
inhibitor
Yes 2
Lum Lumican 1 2
Dcn Decorin Yes 2
Cycs Cytochrome c, somatic Yes 1,96
Peg10 Paternally expressed 10 1,2 1,9
Mfap5 Microfibrillar associated
protein 5
1 1,8
Itm2a Integral membrane protein
2A
Yes 1,8
Penk1 Preproenkephalin 1 1,7
S100a10 S100 calcium binding
protein A10 (calpactin)
Yes 1,7
Igf2 Insulin-like growth factor
2
1 1,6
Ctsc Cathepsin C 1 1,6
Scand1 SCAN domain-containing
1
Yes 1,6
Cox7c Similar to cytochrome c
oxidase, subunit VIIc
1 1,6
Ndufb4 NADH dehydrogenase
(ubiquinone) 1 beta
subcomplex 4
Yes 1,6
Uqcrb Ubiquinol-cytochrome c
reductase binding protein
Yes 1,6
Cox7b Cytochrome c oxidase
subunit VIIb
Yes 1,6
Gja1 Gap junction protein,
alpha 1
Yes 1,6
Dpt Dermatopontin 1 1,57
Cox7c Cytochrome c oxidase, 1,2 1,5
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subunit VIIc
Gabrq Gamma-aminobutyric
acid (GABA-A) receptor,
subunit theta
1 1,5
Mustn1 Musculoskeletal,
embryonic nuclear protein
1
Yes 1,5
Vim Vimentin Yes 1,5
Col1a2 Collagen, type I, alpha 2 Yes 1,5
Genes which increased in expression at least 1,5-fold with p-values  0.05 are reported.
*according to EST database (http://www.ncbi.nlm.nih.gov/nucest)
1 Burniat A et al., 2008, according to UniGene (http://www.ncbi.nlm.nih.gov/unigene)
2 Su AI et al., 2002, according to UniGene (http://www.ncbi.nlm.nih.gov/unigene)
4.3 Cre-mediated recombination of floxed Pax8 allele: deletion of the
floxed Pax8 allele mediated by Tg-CreER
In order to inactivate Pax8 only in the adult thyroid, a Tg-CreER murine line
was used. As described in paragraph 1.4.1, this is a transgenic mouse in which
the thyroglobulin promoter drives the expression of a chimeric recombinase
(CreER), in which Cre is fused to a mutated form of the ligand binding domain
of the estrogen receptor. Using this model the recombination between the loxP
sites takes place only in thyroid follicular cells after a treatment with
tamoxifen.
I first generated a Pax8fl/+ on a TgCreER genetic background (Pax8fl/+;TgCreER):
these mice were crossed with an heterozygous mouse for the Pax8 null allele
(Mansouri et al. 1998), to generate the Pax8ko/fl;TgCreER mice (Fig. 31).
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Pax8+/fl;TgCreER Pax8+/ko
Pax8ko/fl;TgCreER
Pax8ko/ko
+ TAMOXIFEN
(5 days)
Figure 31 Breeding scheme between the heterozygous mice for the floxed Pax8 allele, the
heterozygous mice for the Pax8 knock-out allele and the TgCreER transgenic mice.
This breeding strategy allowed to obtain a mouse in which a single Cre-
mediated recombination event for thyrocyte is sufficient to completely ablate
Pax8 in each thyroid cell.
1-month-old mice were subjected to 10 injections of tamoxifen (50mg/Kg body
weight) every 12 hours, their thyroids were dissected at 1, 2 and 3 months after
the end of the treatment and their morphology was analyzed.
As shown in figure 32, these mice thyroids appeared to be normal with a size
and morphology comparable to a wild-type gland. Moreover the histological
analysis of these samples revealed that also the follicular structure has not
changed.
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Figure 32 Morphology and histology of Pax8ko/fl;TgCreER thyroids. 1-month-old mice were injected
with tamoxifen and their thyroids were dissected after 1, 2 and 3 months from the end of the treatment (b-
d and g-h, gross appearance and histological sections respectively). The size of the Pax8ko/fl;TgCreER
thyroid is not very dissimilar from a wt thyroid (a,e). (a-d) Morphology of thyroid of mice Pax8+/+ and
Pax8ko/fl;TgCreER, 1, 2 and 3 months from the end of the treatment, respectively; (e-h) Hematoxilin-eosin
staining on paraffin-embedded sections of thyroid of mice Pax8+/+ and Pax8ko/fl;TgCreER, 1, 2 and 3
months from the end of the treatment, respectively.
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To confirm that the recombination between the two loxP sites correctly
happened, a RT-PCR, as described in paragraph 4.2 (Fig. 33), was performed
on the thyroids of mice sacrificed 1 month after the end of the treatment.
Pax8ko/fl::TgCreER
Pax
8ko
/fl
Pax
8ko
/fl
Pax
8+/
fl ;Tg
Cre
ER
476 bp
112 bp
Pax
8+/
fl ;Tg
Cre
ER
EX2 EX5
RTf1
RTr1
EX3EX2 EX4 EX5
RTf1
RTr1
EX3EX2 EX4 EX5
RTf1
RTr1
Transcription
mRNA wt mRNA afterCRE-mediated
recombination
476 bp 112 bp
a
b
Figure 33 Cre-mediated recombination in Pax8ko/fl;TgCreER mice. (a) The primer RTf1 recognizes the
exon 2 and the primer RTr1 the exon 5; the expected bands were of 476 bps on the wt transcript and 112
bps on the recombinant one; (b) RT-PCR was carried on five different Pax8ko/fl::TgCreER, two Pax8ko/fl
and two Pax8+/fl;TgCreER thyroids collected from mice sacrificed 1 month after the end of the treatment.
In none of the Pax8ko/fl;TgCreER cDNAs analyzed, the recombination between the loxP sites was
complete, in fact, in each sample both the 476 bp wt band and the 112 bp recombinant band are clearly
visible.
The coding regions are represented by grey boxes, loxP sites by solid triangles. Green and red arrows
indicate wt and recombinant products, respectively. The 300bp and 400bp bands, black arrowheads, are
non-specific products in the PCR reaction due to the presence of the Pax8 null allele.
The RT-PCR experiment demonstrated that the Cre-mediated recombination
was not complete.
To better evaluate the recombination efficiency, the amount of non-
recombinant Pax8-floxed allele was compared with that of the recombinant
allele by real-time PCR. For this experiment, Pax8ko/fl;TgCreER 1-month-old
mice were treated with tamoxifen, as previously illustrated, and their thyroids
were dissected after 1 week and 1 month after the end of the treatment.
To detect all the Pax8 transcripts, I designed a couple of primers on the exons 5
and 6 (F5 and R6 on scheme in figure 33), that amplify a product of 100 bp on
both recombinant and non-recombinant transcript. To detect the recombinant
product, I designed a primer spanning between the exons 2 and 5, that together
with the primer R6 amplify a product of 116 bp on the recombinant template
(Fig. 34a).
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In figure 34b the expression value of the non-recombinant Pax8 (Pax8 TOT)
gene is fixed to 1, while the recombinant gene (Rec Pax8) is expressed as fold
of induction on the total Pax8.
In the three samples collected 1 week after the end of the treatment with the
drug, the Cre-mediated recombinant transcript is about 50% of the non
recombinant one. It is worth noting that instead, 1 month after the end of the
treatment the amount of the recombinant product is strongly reduced.
The results obtained from this experiment show that the recombination
frequency of this system model is very low and they appear to be in line with
the absence of an evident phenotype in Pax8ko/fl;TgCreER.
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Figure 34 Real-time PCR performed to quantify the recombinant and non-recombinant Pax8
transcript.
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Figure 34 Real-time PCR performed to quantify the recombinant and non-recombinant Pax8
transcript. (a) Schematic representation of the Pax8 alleles in Pax8ko/fl;TgCreER mouse. After
transcription there are three different Pax8 transcript, one of them derive from the knocked allele and it is
interrupted on the exon 4; the other two transcripts are the wt and recombinant mRNAs. The coding
regions are represented by grey boxes, the neomycin-resistant cassette by a red box. The exons are
numerated; (b) Real-time PCR performed on RNA extracted from thyroids collected 1 week (#1, 2, 3) and
1 month (#4, 5, 6) from the end of the treatment with tamoxifen. The F5 and R6 are the forward and
reverse primer designed on the exons 5 and 6, respectively; the F2/5 primer van amplify only the
recombinant transcript.
Pax8 TOT, analysis performed using the couple of primers F5-R6, Rec Pax8, with F2/5-R6.
An inefficient recombination in the Cre/lox system has been frequently
described in many cases also in the thyroid (Kusakabe et al. 2006) and in the
kidney (Zhang et al. 2009). However, in the murine lines generated, the
expression of Cre recombinase is driven by the Tg promoter, that is able to
control the expression of thyroglobulin, one of the most expressed genes in the
thyroid follicular cell. Furthermore, the use of the transgene TgCre (not
inducible) to disrupt a floxed allele of E cadherin (Calì et al. 2007) has already
been reported. In this case, Cre-mediated deletion has proven to be efficient.
We therefore considered an alternative hypothesis. In the mouse we generated,
Pax8ko/fl;TgCreER, the deletion of the floxed allele completely abolishes the
expression of Pax8, since the other allele is already inactivated. Abolishing
Pax8 in the adult, as in the embryo, could compromise the survival of the cells.
Therefore, in our analysis (Fig. 35) the cells which have undergone
recombination might be underestimated, apparently lowering the efficiency of
recombination.
We then decided to assess the efficiency of Cre-mediated recombination in
Pax8+/fl;TgCreER mice. These mice still have a wild type allele in these mice, so
the recombination of the floxed allele should not affect the survival.
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Figure 35 Analysis of the recombination frequency in Pax8ko/fl;TgCreER and Pax8fl/+;TgCreER mice.
Real-time PCR performed on RNA extracted from thyroids collected 1 week and 1 month from the end of
the treatment with tamoxifen. Pax8 TOT, analysis performed using the couple of primers F5-R6, Rec
Pax8, with F2/5-R6. cKO-1W and wt-1W indicate the Pax8ko/fl;TgCreER and Pax8+/+;TgCreER samples
collected 1 week after the end of the treatment. cKO-1M and wt-1M indicate the Pax8ko/fl;TgCreER and
Pax8+/+;TgCreER samples collected 1 month after the end of the treatment.
In this case (Fig. 35), recombination efficiency is almost 100%, in both the
samples collected 1 week and 1 month after the end of the treatment. This
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result suggests the hypothesis that Cre activation is equally efficient in the
Pax8ko/fl;TgCreER mice, but that the cells with Pax8 null phenotype are
eliminated. As a consequence, the cells in which recombination has not
occurred could proliferate and reconstitute an appropriate organization of the
gland.
To confirm this hypothesis, thyroid sections of mice injected with tamoxifen
for 5 days and sacrificed 1 week and 1 month after the treatment were stained
for Ki-67, to verify the presence of a cellular proliferation activity. In fact,
Ki67 is a nuclear protein expressed in all active phases of the cell cycle and for
this reason it is used to identify duplicating cells. A higher level of Ki67-
expression indicates an increase in mitotic cell activity and proliferation.
The panels in figure 36 show that, a week after the end of the treatment, the
number of Ki67 positive cells is comparable between mutant
(Pax8ko/fl;TgCreER) and control thyroids (Pax8ko/fl) (Fig. 36 a, b), while in the
thyroids collected 1 month after the end of the treatment, the number of these
cells increases about 10-fold after Cre recombinase induction (Fig. 36 c, d).
To identify when the proliferation activity exactly starts to be detectable, the
immuno-histochemistry assay with anti-Ki67 was also performed on thyroids
collected 1 week after the end of the treatment, but in that case no differences
in Ki67 expression were detected between the conditional knock out and the
controls (Fig. 36 a,b).
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Figure 36 Proliferation assay by immunostaining of Ki67 on paraffin-embedded thyroid sections of
Pax8ko/fl;TgCreER and Pax8ko/fl mice. The number of Ki67-positive nuclei in sections of
Pax8ko/fl;TgCreER thyroid, dissected 1 week after the end of the treatment with the drug (a,b), is
comparable with that found in the control mice. This rate is remarkably increased, almost 10-fold,  in the
thyroids collected 1 month after the tamoxifen treatment (c,d).
Taken together, these data suggest that the absence of a clear phenotype in the
Pax8ko/fl;TgCreER thyroid could be due to the compensatory  proliferation of
cells in which Pax8 has not been inactivated. Further experiments are required
to determine if these cells are completely differentiated cells, or progenitor
cells not yet fully differentiated.
Conclusions
63
CONCLUSIONS
Conventional Pax8 null mice have been a valuable model to demonstrate that
this transcription factor is absolutely required for the development of the
thyroid. In this mouse strain the thyroid primordium disappears before thyroid
follicular cells accomplish their differentiation (at E11). Hence, Pax8-/- mice
are not of value for studying the role of Pax8 in the thyroid during the late
stages of development and/or in postnatal life. All the available data on Pax8
functions in differentiated cells come from studies on cell lines in culture.
During my thesis work I have generated a novel mice strain that allows a
conditional disruption of Pax8 gene in thyroid using the Cre/lox system. This
strain has allowed me to study in vivo the role of Pax8 in the differentiated
thyroid follicular cells.
The phenotype of the Pax8Cre/fl mouse is manifest at birth and confirms that
Pax8 has a key role in cellular differentiation. Many thyroid-specific genes are
down regulated in its absence. Notably, the expression of genes devoted both to
hormone production, such as Thyroglobulin TPO, NIS, Na+/K+-ATPases and
to regulative functions, such as Foxe1, Dream, Tshr, is completely abolished.
We cannot conclude that all these genes are direct targets of Pax8. As an
example, the disruption of Pax8 causes a strong down regulation of Tshr
which, together with its cognate ligand TSH, tightly controls the expression of
both NIS and TPO as demonstrated in animal models (Postiglione et al. 2002).
In any case, Pax8 seems to have a high position in the hierarchy that maintains
the differentiation phenotype of thyroid cells. This scenario resembles what
occurs during thyroid morphogenesis. At this stage, Pax8 holds a specific
upstream role in the genetic regulatory cascade which controls thyroid
development (Parlato et al. 2004). According to the hypothesis that Pax8 has a
unique role in cellular differentiation, there are the data describing the
conditional knock out of Titf1, another non-dispensable gene for thyroid
development. Mice in which Titf1 has been disrupted late during
organogenesis show both a hypoplastic thyroid and impaired follicular
structure but thyroid function is maintained almost normally, with a trend of
slight hypothyroidism.
Histological analysis of Pax8Cre/fl mice shows that thyroid is hypoplastic and
molecular studies reveal a significant up regulation of genes involved in cell
death process. An essential role of Pax8 for the survival of thyroid cells is not
unexpected, because in conventional Pax8 null mice the thyroid cell precursors
disappear at E11. However, in this strain, the lack of Pax8 is accompanied by
loss of both Titf1 and Hhex, making it hard to understand the “prime mover” of
cell death phenotype. On the contrary, in Pax8Cre/fl mice both Titf1 and Hhex
do not appear to be down regulated. Hence, Pax8 absence could be the only
factor or at least the major one, responsible for the cell death process. It is
worth nothing that the role of Pax8 in cell survival seems to be conserved
throughout evolution. In fact, in the nematode C. elegans, two Pax2/5/8-related
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genes play a role in apoptotic mechanisms modulating the transcription of ced-
9, the C. elegans pro-survival bcl-2 gene (Park et al. 2006).
References
65
REFERENCES
Bedford FK, Ashworth A, Enver T, Wiedeann LM. HEX: a novel homeobox gene
expressed during hematopoiesis and conserved between mouse and human.
Nucl. Acid. Res. 1993; 21,1245-1249 .
Bogue CW, Ganea GR, Sturm E, Ianucci R, Jacobs HC. Hex expression suggests a
role in the development and function of organs derived fromforegut endoderm.
Dev Dyn 2000; 219: 84-89.
Borutaite V, Brown GC. Mitochondrial regulation of caspase activation by cytochrome
oxidase and tetramethylphenylenediamine via cytosolic cytochrome c redox
state. J Biol Chem. 2007; 282(43):31124-30.
Bouchard M, Souabni A, Mandler M, Neubuser A, Busslinger M.. Nephric lineage
specification by Pax2 and Pax8. Genes Dev 2002; 16: 2958-70.
Bouchard M, Souabni A, Busslinger M. Tissue-Specific Expression of Cre
Recombinase from the Pax8 Locus. Genesis 2004; 38, 105-109.
Bradley A. Modifying the mammalian genome by gene targeting. Curr Opin
Biotechnol 2 1991; 823 – 9 .
Bradley A. Site-directed mutagenesis in the mouse. Recent Prog Horm Res 1993; 48,
237 – 51 .
Brickman JM, Jones CM, Clements M, Smith JC, Beddington Rs. Hex is a
transcriptional repressor that contributes to anterior identity and suppresses
Spemann organizer function. Development 2000; 127, 2303-2315.
Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L,
Sogayar MC, Bal de Kier Joffé E, Peters MG. Glypican-3 reexpression
regulates apoptosis in murine adenocarcinoma mammary cells modulating
PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat. 2010;
119(3):559-74.
Burniat A, Jin L, Detours V, Driessens N, Goffard JC, Santoro M, Rothstein J,
Dumont JE, Miot F, Corvilain B. Gene expression in RET/PTC3 and E7
transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and
References
66
transient models of human papillary thyroid cancers. Endocrinology 2008;
149(10):5107-17.
Cai CL, Liang X, Shi Y, Chu PH, Chu PH, Pfaff SL, Chen J, Evans S. Isl1 identifies a
cardiac progenitor population that proliferates prior to differentiation and
contributes a majority of cells to the heart. Dev Cell 2003; 5(6): 877-89.
Calì G, Zannini M, Rubini P, Tacchetti C, D'Andrea B, Affuso A, Wintermantel T,
Boussadia O, Terracciano D, Silberschmidt D, Amendola E, De Felice M,
Schütz G, Kemler R, Di Lauro R, Nitsch L. Conditional inactivation of the E-
cadherin gene in thyroid follicular cells affects gland development but does not
impair junction formation. Endocrinology 2007; 148(6):2737-46.
Cardoso WV and Lu J. Regulation of early lung morphogenesis: questions, facts and
controversies. Development 2006; 133: 1611-24.
Cassuto E, Lash T, Sriprakash KS, Radding CM. Role of exonuclease and protein of
phage lambda in genetic recombination. V. Recombination of lambda DNA in
vitro. Proc. Natl. Acad. Sci. USA 1971;68:1639–43.
Chadwick BP, Obermayr F, Frischau A. FKHL15, a new human member of the
forkhead gene family located on chromosome 9q22. Genomics 1997; 41: 390-
396.
Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC, Cheung AN. Tumor suppressor effect
of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential
expression and functional analysis. Carcinogenesis 2009; 30(1):114-21.
Chen CY, Kimura H, Landek-Salgado MA, Hagedorn J, Kimura M, Suzuki K, Westra
W, Rose NR, Caturegli P. Regenerative potentials of the murine thyroid in
experimental autoimmune thyroiditis: role of CD24. Endocrinology 2009;
150(1):492-9.
Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein
essential for tissue-specific expression of the thyroglobulin promoter. EMBO J
1989; 8, 2537-2542.
References
67
Copeland NG, Jenkins NA, Court DL. Mouse genomic technologies recombineering: a
powerful new tool for mouse functional genomics. Nat. Rev. Genet 2001;
2:769–79.
Court DL, Sawitzke JA, Thomason LC. Genetic engineering using homologous
recombination. Annu. Rev. Genet 2002; 36:361–88.
Crompton MR, Bartlett TJ, MacGregor AD, Manfioletti G, Buratti E, Giancotti V,
Goodwin GH. Identification of a novel vertebrate homeobox gene expressed in
haematopoietic cells. Nucl. Acids. Res. 1993, 20, 5661-5667.
D'Andrea B, Di Palma T, Mascia A, Motti ML, Viglietto G, Nitsch L, Zannini. The
transcriptional repressor DREAM is involved in thyroid gene expression. Exp
Cell Res 2005; 305: 166-78.
D'Andrea B, Iacone R, Di Palma T, Nitsch R, Baratta MG, Nitsch L, Di Lauro R,
Zannini M. Functional inactivation of the transcription factor Pax8 through
oligomerization chain reaction. Mol Endocrinol 2006; 20: 1810-24.
Damante G, Tell G, Di Lauro R. A unique combination of transcription factors
controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 2001;
66: 307-56.
Dathan N, Parlato R, Rosica A, De Felice M, Di Lauro R. Distribution of the
titf2/foxe1 gene product is consistent with an important role in the
development of foregut endoderm, palate, and hair. Dev Dyn 2002; 224: 450-6.
De Felice M, Damante G, Zannini MS, Francis-Lang H, Di Lauro R. Redundant
domains contribute to the transcriptional activity of Thyroid Transcription
Factor 1(TTF-1). J Biol Chem 1995; 270: 26649-26656.
De Felice M and Di Lauro R. Thyroid development and its disorders: genetics and
molecular mechanisms. Endocr Rev 2004; 25: 722-46.
De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K,
Macchia PE, Mattei MG, Mariano A, Schöler H, Macchia V, Di Lauro R. A
mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet
1998; 19: 395-398.
References
68
De Felice M, Postiglione MP, Di Lauro R. Minireview: thyrotropin receptor signaling
in development and differentiation of the thyroid gland: insights from mouse
models and human diseases. Endocrinology 2004; 145: 4062-7.
Di Lauro R and M. De Felice. Factors in differentiation and morphogenesis of the
thyroid gland. Topical Endocrinology 2003; 21: 13-17.
Di Palma, T., R. Nitsch, A. Mascia, L. Nitsch, R. Di Lauro, Zannini M. The paired
domain-containing factor Pax8 and the homeodomain-containing factor TTF-1
directly interact and synergistically activate transcription. J Biol Chem 2003;
278(5): 3395-402.
Elsalini OA, von Gartzen J, Cramer M, Rohr KB. Zebrafish hhex, nk2.1a, and pax2.1
regulate thyroid growth and differentiation downstream of Nodal-dependent
transcription factors. Dev Biol 2003; 263: 67-80.
Fabbro D, Pellizzari L, Mercuri F, Tell G, Damante G. Pax-8 protein levels regulate
thyroglobulin gene expression. J Mol Endocrinol 1998; 21: 347-54.
Fagman H, Andersson L, Nilsson M. The developing mouse thyroid: embryonic vessel
contacts and parenchymal growth pattern during specification, budding,
migration, and lobulation. Dev Dyn. 2006; 235(2):444-55.
Fagman H, Grande M, Edsbagge J, Semb H, Nilsson M. Expression of classical
cadherins in thyroid development: maintenance of an epithelial phenotype
throughout organogenesis. Endocrinology 2003; 144: 3618-24.
Fagman H, Grande M, Gritli-Linde A, Nilsson M. Genetic deletion of sonic hedgehog
causes hemiagenesis and ectopic development of the thyroid in mouse. Am J
Pathol 2004; 164: 1865-72.
Fagman H, Liao J, Westerlund J, Andersson L, Morrow BE, Nilsson M. The 22q11
deletion syndrome candidate gene Tbx1 determines thyroid size and
positioning. Hum Mol Genet. 2007; 16(3):276-85.
Fontaine J. Multistep migration of calcitonine cell precursors during ontogeny of the
mouse pharynx. Gen Comp Endocrinol 1979; 37: 81-92.
References
69
Francis-Lang H, Zannini M, De Felice M, Berlingieri MT, Fusco A, Di Lauro R.
Multiple mechanisms of interference between transformation and
differentiation in thyroid cells. Mol. Cell. Biol. 1992; 12, 5793-5800.
Frigerio G, Burri M, Bopp D, Baumgartner S, Noll M. Structure of the segmentation
gene paired and the Drosophila PRD gene set a part of a gene network. Cell
1986; 47, 735-746.
Fukuda, K. and Y. Kikuchi. Endoderm development in vertebrates: fate mapping,
induction and regional specification." Develop. Growth Differ. 2005; 47: 343-
355.
Ghosh B, Jacobs HC, Wiedemann LM, Brown A, Bedford FK, Nimmakayalu MA,
Ward DC, Bogue CW. Genomic structure, cDNA mapping, and chromosomal
localization of the mouse homeobox gene, Hex. Mamm Genome 1999; 10:
1023-5.
Goffard JC, Jin L, Mircescu H, Van Hummelen P, Ledent C, Dumont JE, Corvilain B.
Gene expression profile in thyroid of transgenic mice overexpressing the
adenosine receptor 2a. Mol Endocrinol. 2004; 18(1):194-213.
Grapin-Botton A and Melton M. Endoderm development: from patterning to
organogenesis. Trends Genet 2000; 16: 124-30.
Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R. Thyroid nuclear
factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding
specificity. EMBO J 1990; 9(11): 3631-3639.
Hamdan H, Liu H, Li C, Jones C, Lee M, deLemos R, Minoo P. Structure of the
human Nkx2.1 gene. Biochim Biophys Acta 1998; 1396, 336-348.
Hewitt SM, Hamada S, Monarres A, Kottical LV, Saunders GF, McDonnell TJ.
Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired
box transcription factor PAX8. Anticancer Res. 1997; 17(5A):3211-5.
Hilfer SR and Brown JW. The development of pharyngeal endocrine organs in mouse
and chick embryos. Scan Electron Microsc 1984; 4: 2009-22.
References
70
Ho CY, Houart C, Wilson SW, Stainier DY. A role for the extraembryonic yolk
syncytial layer in patterning the zebrafish embryo suggested by properties of
the hex gene. Curr. Biol. 1999; 9, 1131-1134.
Hoess RH, Ziese M, Sternberg N. P1 site-specific recombination: nucleotide sequence
of the recombining sites. Proc. Natl. Acad. Sci. USA 1982; 79, 3398-3402
Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo: a
laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor
Laboratory Press 1994.
Hogan B and Zaret K. Development of the endoderm and its tissue derivatives Mouse
development: Patterning, Morphogenesis, and Organogenesis. J. Rossant and
T. PP. New York, Academic Press 2002; 301-310.
Horie K, Nishiguchi S, Maeda S, Shimada K. Structures of replacement vectors for
efficient gene targeting. J Biochem 1994; 115, 477 – 85 .
Hromas R, Radich J, Collins S. PCR cloning of an orphan homeobox gene (PRH)
preferentially expressed in myeloid and liver cells. Biochem Biophys Res
Commun 1993; 195: 976-983.
Ikeda K, Clark JC, Shaw-White JR, Stahlman MT, Boutell CJ, Whitsett JA. Gene
structure and expression of human thyroid transcription factor-1 in respiratory.
J. Biol. Chem. 1996; 271, 2249-2254.
Joiner AL (). Gene targeting: a pratical approach. Oxford, United Kingdom: IRL Press
1993.
Kaestner KH, Lee KH, Schlondorff J, Hiemisch H, Monaghan AP,  Schutz G. Six
members of the mouse forkhead gene family are developmentally regulated.
Proc Natl Acad Sci U S A 1993; 90: 7628-7631.
Kaufman MH and Bard J. The thyroid. The anatomic basis of mouse development.
Kaufman MH and Bard J. San Diego, Academic Press1999; 165-166.
Kehrer JP. Lipocalin-2: pro- or anti-apoptotic?. Cell Biol Toxicol. 2010; 26(2):83-9.
Kim G, Lee T, Wetzel P, Geers C, Robinson MA, Myers GT, Owens WJ, Wehr BN,
Eckhaus W Michael, Gros G, Wynshaw-Boris A, Levine LR. Carbonic
References
71
Anhydrase III Is Not Required in the Mouse for Normal Growth, Development,
and Life Span. Mol Cell Bio 2004; 24(22):9942-7
Kim Y, and Niremberg M. Drosophila NK-homeobox genes. Proc. Natl. Acad. Sci.
USA 1989; 86, 7716-7720.
Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ.
The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential
for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary.
Genes Dev 1996; 10: 60-69.
Kimura S, Ward JD, Minoo P. Thyroid -specific enhancer -binding
protein/transcription factor 1 is not required for the initial specification of the
thyroid and lung primordia. Biochemie 1999; 81: 321-328.
Kozmik Z, Kurzbauer R, Dörfler P, Busslinger M. Alternative splicing of Pax-8 gene
transcripts is developmentally regulated and generates isoforms with different
transactivation properties. Mol Cell Biol 1993;13: 6145-6149.
Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S Kimura S. Thyroid-
specific enhancer-binding protein/NKX2.1 is required for the maintenance of
ordered architecture and function of the differentiated thyroid. Mol Endocrinol.
2006; 20: 1796-809.
Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE Jr. Hepatocyte nuclear factor 3
alpha belongs to a gene family in mammals that is homologous to the
Drosophila homeotic gene forkhead. Genes Dev 1991, 5:416-427.
Lammert E, Cleaver O, Melton D. Role of endothelial cells in early pancreas and liver
development. Mech Dev 2003; 120: 35-43.
Lazzaro D, Price M, De Felice M, Di Lauro R. The transcription factor TTF-1 is
expressed at the onset of thyroid and lung morphogenesis and in restricted
regions of the foetal brain. Development 1991; 113: 1093-1104.
Le Douarin N, Fontaine J, LeLievre C. New studies on the neural crest origin of the
avian ultimobranchial glandular cells. Interspecific combinations and
cytochemical characterization of C cells based on the uptake of biogenic amine
precursors. Histochemie 1974; 38: 297-305.
References
72
Lonigro R, De Felice M, Biffali E, Macchia PE, Damante G, Asteria C and Di Lauro
R. Expression of thyroid transcription factor 1 gene can be regulated at the
transcriptional and posttranscriptional levels. Cell Growth Differ 1996; 7: 251-
61.
Macchia PE, Mattei MG, Lapi P, Fenzi G, Di Lauro R. Cloning, chromosomal
localization and identification of polymorphisms in the human thyroid
transcription factor 2 gene (TITF2). Biochimie 1999; 81: 433-40.
Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8
gene function. Nat Genet 1998; 19: 87-90.
Martinez Barbera JP, Clements M, Thomas P, Rodriguez T, Meloy D, Kioussis D,
Beddington RS. The homeobox gene Hex is required in definitive endodermal
tissues for normal forebrain, liver and thyroid formation. Development 2000;
127: 2433-45.
Meunier D, Aubin J, Jeannotte L. Perturbed thyroid morphology and transient
hypothyroidism symptoms in Hoxa5 mutant mice. Dev Dyn 2003; 227: 367-78.
Miccadei S, De Leo R, Zammarchi E, Natali PG, Civitareale D. The synergistic
activity of thyroid transcription factor 1 and Pax8 relies on the
promoter/enhancer interplay. Mol. Endocrinol. 2002; 16, 837-846.
Minoo P, Su G, Drum H, Bringas P, Kimura S. Defects in tracheoesophageal and lung
morphogenesisn in Nkx2.1(-/-) mouse embryos. Devel Biol 1999; 209: 60-71.
Motran CC, Molinder KM, Liu SD, Poirier F, Miceli MC. Galectin-1 functions as a
Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2
function. Eur J Immunol. 2008; 38(11):3015-27.
Murray D. The thyroid gland. In: Kovacs K, Asa SL, eds. functional endocrine
pathology. Malden, MA: Blackwell Science, Inc. 1998; 295-380.
Mythili E, Kumar KA, Muniyappa K. Characterization of the DNA-binding domain of
beta protein, a component of phage lambda red-pathway, by UV catalyzed
cross-linking. Gene 1996;182:81–7.
Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2(3): 165-74.
References
73
Nagy A. Cre recombinase: the universa lreagent for genome tailoring. Genesis
2000;26:99–109.
Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, Itoh N. FGF10 acts as a
major ligand for FGF receptor 2 IIIb in mouse multi-organ development.
Biochem Biophys Res Commun 2000; 277: 643-9.
Okladnova O, Poleev A, Fantes J, Lee M, Plachov D, Horst J. The genomic
organization of the murine Pax 8 gene and characterization of its basal
promoter. Genomics 1997; 15: 452-61.
Ortiz L, Zannini MS, Di Lauro R Santisteban P. Transcriptional control of the
forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin and insulin-
like growth factor 1. J Biol Chem 1997; 272: 23334-23339.
Park D, Jia H, Rajakumar V, Chamberlin MH. Pax2/5/8 proteins promote cell survival
in C. elegans2.  Development 2006; 133, 4193-4202
Parlato R, Avantaggiato V, De Felice M. TTF-1 and TTF-2 identify two different steps
in thyroid morphogenesis. J. Endocrinol. Invest. 1999; 22 (Suppl), 4
Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, Arra C,
Mansouri A, Kimura S, Di Lauro R, De Felice M. An integrated regulatory
network controlling survival and migration in thyroid organogenesis. Dev Biol
2004; 276: 464-475.
Pasca di Magliano M, Di Lauro R, Zannini MS. Pax8 has a key role in thyroid cell
differentiation. Proc Natl Acad Sci U S A 2000; 97: 13144-9.
Pellizzari L, D'Elia A, Rustighi A, Manfioletti G, Tell G, Damante G. Expression and
function of the homeodomain-containing protein Hex in thyroid cells. Nucleic
Acids Res 2000; 28: 2503-11.
Perrone L, Pasca di Magliano M, Zannini MS, Di Lauro R. The thyroid transcription
factor 2 (TTF-2) is a promoter-specific DNA-binding independent
transcriptional repressor. Biochem Biophys Res Commun 2000; 275: 203-8.
Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, Gruss P. Pax8, a murine
paired box gene expressed in the developing excretory system and thyroid
gland. Development 1990; 110: 643-651.
References
74
Poleev A, Wendler F, Fickenscher H, Zannini MS, Yaginuma K, Abbott C, Plachov D.
Distinct functional properties of three human paired-box-protein, PAX8,
isoforms generated by alternative splicing in thyroid, kidney and Wilms'
tumors." Eur J Biochem1995; 228: 899-911.
Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M,
Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R. Role of the
thyroid-stimulating hormone receptor signaling in development and
differentiation of the thyroid gland. Proc Natl Acad Sci U S A 2002; 99:
15462-7.
Puppin C, D'Elia AV, Pellizzari L, Russo D, Arturi F, Presta I, Filetti S, Bogue CW,
Denson LA, Damante G. Thyroid-specific transcription factors control Hex
promoter activity. Nucleic Acids Res 2003; 31: 1845-52.
Romanelli MG, Lorenzi P, Morandi C. Nuclear localization domains in human thyroid
transcription factor 2. Biochim Biophys Acta2003; 1643: 55-64.
Rutledge RG and Cote C (2003). "Mathematics of quantitative kinetic PCR and the
application of standard curves." Nucleic Acids Res. 31: e93.
Santisteban P, Acebrón A, Polycarpou-Schwarz M, Di Lauro R. Insulin and insulin-
like growth factor I regulate a thyroid-specific nuclear protein that binds to the
thyroglobulin promoter. Mol Endocrinol 1992; 6:1310-1317.
Sawitzke JA, Thomason LC, Costantino N, Bubunenko M, Datta S, Court DL.
Recombineering: in vivo genetic engineering in E. coli, S. enterica, and
beyond". Methods Enzymol 2007; 421:171–99.
Sequeira M, Al-Khafaji F, Park S, Lewis MD, Wheeler MH, Chatterjee VK, Jasani B,
M. Ludgate Production and application of polyclonal antibody to human
thyroid transcription factor 2 reveals thyroid transcription factor, 2 protein
expression in adult thyroid and hair follicles and prepubertal testis. Thyroid
200313: 927-32.
Shivdasani R. Molecular regulation of vertebrate early endoderm development. Dev
Biol 2002 249: 191-203.
References
75
Stapleton P, Weith A, P. Urbanek, Z. Kozmik, M. Busslinger. Chromosomal
localization of 7 Pax genes and cloning of a novel family member, Pax-9.
Nature Genet. 1993; 3: 292-298.
Su AI, Cooke MP, Ching KA, Hakak, Walker JR, Wiltshire T, Orth AP, Vega RG,
Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG,
Hogenesch JB. Large-scale analysis of the human and mouse transcriptomes.
Proc Natl Acad Sci U S A. 2002; 99(7):4465-70.
Suzuki K, Kobayashi Y, Katoh R, Kohn LD and A. Kawaoi. Identification of thyroid
transcription factor-1in C cells and parathyroid cells. Endocrinology 1998; 139:
3014-3017.
Takuma N, Sheng HZ, Furuta Y, Ward JM, Sharma K, Hogan BL, Pfaff SL, Westphal
H, Kimura S, Mahon KA. Formation of Rathke's pouch requires dual induction
from the diencephalon. Development 1998; 125: 4835-4840.
Tanaka T, Inazu T, Yamada K, Myint Z, Keng VW, Inoue Y, Taniguchi N, Noguchi
T. DNA cloning and expression of rat homeobox gene, Hex, and functional
characterization of the protein. Biochem J 1999; 339: 111-7.
Thomas KR and Capecchi MR. Site-directed mutagenesis by gene targeting in mouse
embryo-derived stem cells. Cell 1987; 51: 503-511
Thiery JP and J. Sleeman. Complex networks orchestrate epithelial-mesenchymal
transitions. Nat Rev Mol Cell Bio 2006; 7: 131-42.
Thomas PQ, Brown A and R. Beddington. Hex: a homeobox gene revealing peri-
implantation asymmetry in the mouse embryo and an early transient marker of
endothelial cell precursors. Development 1998; 125: 85-95.
Trueba SS, Auge J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M,
Polak M and Attie-Bitach T. PAX8, TITF1 and FOXE1 gene expression
patterns during human development: new insights into human thyroid
development and thyroid dysgenesis associated malformations. J Clin
Endocrinol Metab 2004; 90: 455-62.
van der Weyden L, Adams DJ, Bradley A. Tools for targeted manipulation of the
mouse genome Physiol Genomics 2002; 11 , 133 – 64 .
References
76
Zannini M, Francis-Lang H, Plachov D, Di Lauro R. Pax8, a paired domain-containing
protein, binds to a sequence overlapping the recognition site of a homeodomain
and activates transcription from two thyroid-specific pronoters. Mol. Cell. Biol.
1992; 12, 4230-4241 ().
Zannini, M, Avantaggiato V, Biffali E, Arnone M, Sato K, Pischetola M, Taylor BA,
Phillips SJA,  Di Lauro R. TTF-2, a new forkhead protein, shows a temporal
expression in the developing thyroid which is consistent with a role in
controlling the onset of differentiation. EMBO J 1997; 16: 3185-3197.
Zannini MS, Acebron A, De Felice M, Arnone MI, Martin J, Santisteban P Di Lauro
R. Mapping and functional role of phosphorylation sites in the Thyroid
Transcription Factor 1 (TTF-1). J Biol Chem 1996; 271: 2249-2254.
Zannini MS, Francis-Lang H, Plachov D, Di Lauro R Pax-8, a paired domain-
containing protein, binds to a sequence overlapping the  recognition site of a
homeodomain and activates transcription from two thyroid-specific promoters.
Mol Cell Biol. 1992; 12: 4230-4241.
Zhang X, Mernaugh G, Yang DH, Gewin L, Srichai MB, Harris RC, Iturregui JM,
Nelson RD, Kohan DE, Abrahamson D, Fässler R, Yurchenco P, Pozzi A, Zent
R; beta1 integrin is necessary for ureteric bud branching morphogenesis and
maintenance of collecting duct structural integrity. Development 2009;
136(19):3357-66.
Zhang Y, Buchholz F, Muyrers JP, Stewart AF. A new logic for DNA engineering
using recombination in Escherichia coli. Nat. Genet. 1998; 20:123–8.
Zheng B, Sage M, Sheppeard EA , Jurecic V, Bradley A. Engineering mouse
chromosomes with Cre-loxP: range, efficiency, and somatic applications. Mol
Cell Biol. 2000; 20:648–55.
